Processing 00000000.tx.1: SERCA3 Ablation Does Not Impair Insulin Secretion but Suggests Distinct Roles of Different Sarcoendoplasmic Reticulum Ca2+ Pumps for Ca2+ Homeostasis in Pancreatic -cells Abdelilah Arredouani1, Yves Guiot2, Jean-Christophe Jonas1, Lynne H. 

Phrase: "SERCA3 Ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Impair"

Phrase: "Insulin Secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "Suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "Distinct Roles of Different Sarcoendoplasmic Reticulum Ca2+ Pumps"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "for Ca2+ Homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "in Pancreatic -cells Abdelilah Arredouani1,"

Phrase: "Yves Guiot2,"

Phrase: "Jean-Christophe Jonas1,"

Phrase: "Lynne H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Liu3, Myriam Nenquin1, Jos A. 

Phrase: "Liu3,"

Phrase: "Myriam Nenquin1,"

Phrase: "Jos A."
Processing 00000000.tx.3: Pertusa1, Jacques Rahier2, Jean-Franois Rolland1, Gary E. 

Phrase: "Pertusa1,"

Phrase: "Jacques Rahier2,"

Phrase: "Jean-Franois Rolland1,"

Phrase: "Gary E."
Processing 00000000.tx.4: Shull3, Martine Stevens2, Frank Wuytack4, Jean-Claude Henquin1, and Patrick Gilon1 1 Unit dEndocrinologie et Mtabolisme, University of Louvain Faculty of Medicine, Brussels, Belgium 2 Unit dAnatomie Pathologique Spciale, University of Louvain Faculty of Medicine, Brussels, Belgium 3 Department of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, Ohio 4 Laboratorium voor Fysiologie, Katholieke Universiteit Leuven, Leuven, Belgium  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Two sarcoendoplasmic reticulum Ca2+-ATPases, SERCA3 and SERCA2b, are expressed in pancreatic islets. 

Phrase: "Shull3,"

Phrase: "Martine Stevens2,"

Phrase: "Frank Wuytack4,"

Phrase: "Jean-Claude Henquin1,"

Phrase: "and"

Phrase: "Patrick Gilon1 1 Unit dEndocrinologie et Mtabolisme,"

Phrase: "University of Louvain Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Brussels,"

Phrase: "Belgium 2 Unit dAnatomie Pathologique Spciale,"

Phrase: "University of Louvain Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Brussels,"

Phrase: "Belgium 3 Department of Molecular Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587466:Genetics department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "University of Cincinnati College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0557806:College [Manufactured Object]

Phrase: "Cincinnati,"

Phrase: "Ohio 4 Laboratorium voor Fysiologie,"

Phrase: "Katholieke Universiteit Leuven,"

Phrase: "Leuven,"

Phrase: "Belgium  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Two sarcoendoplasmic reticulum Ca2+-ATPases,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   926   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   823   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   771 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA2b,"

Phrase: "are"

Phrase: "expressed in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.5: Immunocytochemistry showed that SERCA3 is restricted to -cells in the mouse pancreas. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: "to -cells in the mouse pancreas."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: Control and SERCA3-deficient mice were used to evaluate the role of SERCA3 in -cell cytosolic-free Ca2+ concentration ([Ca2+]c) regulation, insulin secretion, and glucose homeostasis. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "SERCA3-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the role of SERCA3 in -cell cytosolic-free Ca2+ concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c) regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.7: Basal [Ca2+]c was not increased by SERCA3 ablation. 

Phrase: "Basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased by SERCA3 ablation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0547070:Ablation [Therapeutic or Preventive Procedure]
   770   C1261381:ablation [Therapeutic or Preventive Procedure]
   770   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.8: Stimulation with glucose induced a transient drop in basal [Ca2+]c that was suppressed by inhibition of all SERCAs with thapsigargin (TG) but unaffected by selective SERCA3 ablation. 

Phrase: "Stimulation with glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a transient drop in basal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1321095:Drop [Quantitative Concept]
   760   C1705648:Drop [Activity]
   760   C2347093:Drop [Quantitative Concept]
   760   C2348338:Drop [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "suppressed by inhibition of all SERCAs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1260953:Suppressed [Functional Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "with thapsigargin (TG)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "but"

Phrase: "unaffected by selective SERCA3 ablation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.9: Ca2+ mobilization by acetylcholine was normal in SERCA3-deficient -cells. 

Phrase: "Ca2+ mobilization by acetylcholine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   770   C0300926:mobilization [Functional Concept]

Phrase: "was"

Phrase: "normal in SERCA3-deficient -cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0007634:Normal cell [Cell]
   781   C1268443:Normal cell [Cell]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.10: In contrast, [Ca2+]c oscillations resulting from intermittent glucose-stimulated Ca2+ influx and [Ca2+]c transients induced by pulses of high K+ were similarly affected by SERCA3 ablation or TG pretreatment of control islets; 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "resulting from intermittent glucose-stimulated Ca2+ influx"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0205267:Intermittent [Temporal Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0678226:resulting [Functional Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c transients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040704:Transients [Population Group]
   861   C0687129:Transients [Finding]
   827 E C0205374:Transient [Temporal Concept]

Phrase: "induced by pulses of high K+"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0034107:Pulses [Health Care Activity]
   753   C0205250:High [Qualitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0391850:PULSES [Physiologic Function]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1299351:High [Qualitative Concept]
   753   C1708601:K' [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C1947910:Pulse [Phenomenon or Process]

Phrase: "were"

Phrase: "similarly"

Phrase: "affected by SERCA3 ablation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0392760:Affected [Functional Concept]
   770   C0547070:Ablation [Therapeutic or Preventive Procedure]
   770   C1261381:ablation [Therapeutic or Preventive Procedure]
   770   C1314939:Affected [Functional Concept]
   770   C1412639:SERCA3 [Gene or Genome]
   737 E C0001721:Affect [Mental Process]

Phrase: "or"

Phrase: "TG pretreatment of control islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: ";"
Processing 00000000.tx.11: their amplitude was increased and their slow descending phase suppressed. 

Phrase: "their amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "their slow descending phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205390:Phase [Temporal Concept]

Phrase: "suppressed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]
Processing 00000000.tx.12: This suggests that, during the decay of each oscillation, the endoplasmic reticulum releases Ca2+ that was pumped by SERCA3 during the upstroke phase. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "during the decay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1265875:Decay [Acquired Abnormality]
  1000   C2700592:Decay [Phenomenon or Process]

Phrase: "of each oscillation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "that"

Phrase: "was"

Phrase: "pumped by SERCA3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0182537:pumped [Medical Device]
   790   C1412639:SERCA3 [Gene or Genome]
   756 E C1706421:Pump [Manufactured Object]

Phrase: "during the upstroke phase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.13: SERCA3 ablation increased the insulin response of islets to 15 mmol/l glucose. 

Phrase: "SERCA3 ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the insulin response of islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to 15 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.14: However, basal and postprandial plasma glucose and insulin concentrations in SERCA3-deficient mice were normal. 

Phrase: "However,"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "postprandial plasma glucose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0376674:Postprandial [Temporal Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "insulin concentrations in SERCA3-deficient mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.15: In conclusion, SERCA2b, but not SERCA3, is involved in basal [Ca2+]c regulation in -cells. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "SERCA2b,"

Phrase: "but"

Phrase: "not SERCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "involved in basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205112:Basal [Spatial Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c regulation in -cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0229579:C-Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.16: SERCA3 becomes operative when [Ca2+]c rises and is required for normal [Ca2+]c oscillations in response to glucose. 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "becomes"

Phrase: "operative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882154:Operative [Temporal Concept]

Phrase: "when"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rises"

Phrase: "and"

Phrase: "is"

Phrase: "required for normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C1514873:Required [Functional Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.17: However, a lack of SERCA3 is insufficient in itself to alter glucose homeostasis or impair insulin secretion in mice.  

Phrase: "However,"

Phrase: "a lack of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "is"

Phrase: "insufficient in itself to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205412:Insufficient [Qualitative Concept]
   770   C0231180:Insufficient [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "or"

Phrase: "impair"

Phrase: "insulin secretion in mice."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.18: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) transfers Ca2+ from the cytosol to the lumen of the reticulum. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The sarcoendoplasmic reticulum Ca2+-ATPase (SERCA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "transfers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040671:Transfer [Mental Process]
  1000   C0728827:Transfers [Finding]
  1000   C1705822:Transfer [Activity]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "to the lumen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "of the reticulum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035295:Reticulum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.19: Three SERCA genes (SERCA13) have been identified, all of which can generate several alternatively spliced isoforms (14). 

Phrase: "Three SERCA genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C1413043:CA2 gene [Gene or Genome]
   810   C1706675:ATPase Gene [Gene or Genome]
   799   C0017337:Genes [Gene or Genome]
   734   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SERCA13"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "can"

Phrase: "generate"

Phrase: "several alternatively spliced isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.20: Pancreatic islets express SERCA2b and the three isoforms of SERCA3 (ac) (1,5). 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "express"

Phrase: "SERCA2b"

Phrase: "and"

Phrase: "the three isoforms of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(ac) (1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: SERCA2b is nearly ubiquitous and considered essential for viability (68). 

Phrase: "SERCA2b"

Phrase: "is"

Phrase: "nearly ubiquitous"

Phrase: "and"

Phrase: "considered essential for viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.22: SERCA3 has a restricted tissue distribution (4,9,10) and shows lower Ca2+ affinity, higher sensitivity to vanadate, and higher pH optimum than SERCA1 or SERCA2 (11). 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "has"

Phrase: "a restricted tissue distribution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0040287:Tissue Distribution [Quantitative Concept]
   901   C0220927:tissue distribution [Functional Concept]
   827   C0040300:Tissue [Tissue]
   827   C0520511:distribution [Idea or Concept]
   827   C1547928:Tissue [Intellectual Product]
   827   C1704711:Distribution [Functional Concept]

Phrase: "(4,"

Phrase: "9,"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "lower Ca2+ affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "higher sensitivity to vanadate,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   816   C1441604:High sensitivity [Laboratory Procedure]
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "higher pH optimum than SERCA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2698651:Optimum [Qualitative Concept]

Phrase: "or"

Phrase: "SERCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916183:serca2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412638:SERCA2 [Gene or Genome]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: The evidence for distinct physiological roles of the various SERCAs in cells is scant (3,12,13) and difficult to obtain because it requires experiments with genetically modified mouse or cell models or analysis of spontaneously occurring genetic diseases (8). 

Phrase: "The evidence for distinct physiological roles of the various SERCAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "scant"

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "12,"

Phrase: "13"

Phrase: ")"

Phrase: "and"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "requires"

Phrase: "experiments with genetically modified mouse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "or"

Phrase: "cell models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "or"

Phrase: "analysis of spontaneously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "genetic diseases"
Meta Candidates (Total=23; Excluded=18; Pruned=0; Remaining=5)
  1000   C2316203:Genetic diseases [Finding]
  1000   C2924406:Genetic diseases [Laboratory Procedure]
   966 E C0019247:Genetic disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.24: Glucose-stimulated -cells display oscillations of the membrane potential that cause intermittent openings of voltage-dependent Ca2+ channels (14) and induce synchronous cytosolic-free Ca2+ concentration ([Ca2+]c) oscillations (15,16). 

Phrase: "Glucose-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "stimulated -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "oscillations of the membrane potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "intermittent openings of voltage-dependent Ca2+ channels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0175566:openings [Spatial Concept]
   714 E C1882151:Opening [Spatial Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "synchronous cytosolic-free Ca2+ concentration"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0086045:Concentration [Mental Process]
   804   C0332296:free [Functional Concept]
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1383501:Cytosolic [Cell Component]
   804   C1446561:Concentration [Quantitative Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c) oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.25: The endoplasmic reticulum (ER) plays complex roles in -cell Ca2+ homeostasis. 

Phrase: "The endoplasmic reticulum (ER)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "complex roles in -cell Ca2+ homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.26: Upon stimulation by glucose, it sequesters Ca2+ (1719), leading to a lowering of [Ca2+]c if Ca2+ influx is prevented. 

Phrase: "Upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "it"

Phrase: "sequesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(1719"

Phrase: ")"

Phrase: ","

Phrase: "leading to a lowering of [Ca2+"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   753   C0332152:Leading [Temporal Concept]
   753   C0441994:lowering [Spatial Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1522538:Leading [Functional Concept]
   753   C2003888:Lowering [Activity]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1548802:Lower [Body Location or Region]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "if"

Phrase: "Ca2+ influx"

Phrase: "is"

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.27: Upon stimulation by phospholipase Cactivating agonists, such as acetylcholine (ACh) (17,20), it massively releases Ca2+. 

Phrase: "Upon stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by phospholipase Cactivating agonists,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]

Phrase: "such as acetylcholine (ACh)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(17,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "it massively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Massively [Qualitative Concept]

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Ca2+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.28: During [Ca2+]c oscillations induced by periodic influx of Ca2+, such as those triggered by glucose, the ER takes up Ca2+ during the upstroke of the [Ca2+]c rise and releases it slowly when Ca2+ influx stops (21). 

Phrase: "During"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by periodic influx of Ca2+,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205263:Induced [Functional Concept]
   753   C0332182:Periodic [Temporal Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1706381:PERIODIC [Intellectual Product]

Phrase: "such as those"

Phrase: "triggered by glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1444748:Triggered by [Qualitative Concept]
           Trigger
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   756   C0032930:Trigger [Clinical Attribute]

Phrase: "the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "takes up Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1515187:Take [Health Care Activity]

Phrase: "during the upstroke"

Phrase: "of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise"

Phrase: "and"

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "it slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "when"

Phrase: "Ca2+ influx stops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0450446:Stops [Manufactured Object]
   793 E C1947925:Stop [Activity]
   793 E C2746065:Stop [Temporal Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.29: An impaired [Ca2+]c response to glucose is observed in -cells of animal models of type 2 diabetes (22,23). 

Phrase: "An impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in -cells of animal models of type 2 diabetes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0449475:Type of cell [Intellectual Product]
           cells type
   745 E C0007634:Cell Type [Cell]
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: Several studies have suggested that this dysregulation results from an impaired control of [Ca2+]c by the SERCAs, in particular SERCA3. 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this dysregulation"

Phrase: "results from an impaired control of [Ca2+"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0221099:Impaired [Functional Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0684336:Impaired [Pathologic Function]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2825142:Result [Finding]
   748   C3274648:Control [Qualitative Concept]

Phrase: "]c by the SERCAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "in particular SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.31: Thus, a decreased Ca2+-ATPase activity has been reported in islets of rats made diabetic by neonatal injection of streptozotocin (24). 

Phrase: "Thus,"

Phrase: "a decreased Ca2+-ATPase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0086439:Decreased activity [Sign or Symptom]
   861   C1148926:ATPase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in islets of rats"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "diabetic by neonatal injection of streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0241863:DIABETIC [Finding]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.32: The activity of all SERCAs was also found to be reduced in spontaneously diabetic db/db mice (25). 

Phrase: "The activity of all SERCAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reduced in spontaneously diabetic db/db mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0241863:DIABETIC [Finding]
   748   C0392756:Reduced [Qualitative Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.33: Other studies have suggested that a deficiency of SERCA3 specifically might be involved. 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a deficiency of SERCA3 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011155:Deficiency [Functional Concept]
   760   C0162429:Deficiency [Disease or Syndrome]
   760   C1623416:deficiency [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.34: Indeed, a major decrease of the expression of SERCA3 but not of SERCA2b was observed in Goto-Kakizaki rats (5) and in 90% pancreatectomized rats (26). 

Phrase: "Indeed,"

Phrase: "a major decrease of the expression of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "not of SERCA2b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "was"

Phrase: "observed in Goto-Kakizaki rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1441672:Observed [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and in 90% pancreatectomized rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.35: Several missense mutations of SERCA3 have been detected in type 2 diabetic patients (27). 

Phrase: "Several missense mutations of SERCA3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "detected in type 2 diabetic patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441730:Type 2 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.36: Overexpression of insulin receptor substrate-1, which occurs after prolonged exposure of TC6 cells to insulin (a phenomenon that might occur in hyperinsulinemic patients), inhibited SERCA3 gene expression without affecting that of SERCA2b (28). 

Phrase: "Overexpression of insulin receptor substrate-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514559:Overexpression [Genetic Function]
   716   C0123658:Insulin Receptor Substrate-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1334140:INSULIN RECEPTOR SUBSTRATE 1 [Gene or Genome]

Phrase: "which"

Phrase: "occurs after prolonged exposure of TC6 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0007634:Cells [Cell]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0439590:Prolonged [Temporal Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "a phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "that"

Phrase: "might"

Phrase: "occur in hyperinsulinemic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "SERCA3 gene expression without affecting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017262:Gene Expression [Genetic Function]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that of SERCA2b"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.37: All of these data therefore suggest that a decreased expression or activity of SERCA3 could contribute to the impaired -cell [Ca2+]c and insulin responses observed in type 2 diabetes. 

Phrase: "All of these data therefore"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0444868:All [Quantitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
   760   C3539085:All [Idea or Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a decreased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "activity of SERCA3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "contribute to the impaired -cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "insulin responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "observed in type 2 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.38: In the present study, we studied by immunocytochemistry the specific cell localization of SERCA3 in islets. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "studied by immunocytochemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0242349:Immunocytochemistry [Laboratory Procedure]
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "the specific cell localization of SERCA3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1660153:localisation of cell [Biologic Function]
           cell localization
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in islets."
Processing 00000000.tx.39: Then, we addressed the role of SERCA3 in -cell Ca2+ signaling by using the recently generated SERCA3 knockout mice (SERCA3 -/-) (29) and their wild-type littermates (SERCA3 +/+). 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the role of SERCA3 in -cell Ca2+ signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the recently generated SERCA3 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "their wild-type littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.40: The [Ca2+]c response to various agents was compared in -cells expressing SERCA2b and SERCA3 (SERCA3 +/+ mice), in cells expressing only SERCA2b (SERCA3 -/- mice), and in cells treated by thapsigargin (TG) to block all SERCA activity (30).  

Phrase: "The [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c response to various agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "SERCA2b"

Phrase: "and"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(SERCA3 +/+ mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "only SERCA2b"

Phrase: "(SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "and in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1515981:And [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated by thapsigargin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "all SERCA activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1148926:ATPase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.41: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Immunodetection of SERCA3 and islet hormones. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Immunodetection of SERCA3"

Phrase: "and"

Phrase: "islet hormones."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.42: The pancreas of adult NMRI mice was fixed with 4% paraformaldehyde and embedded in paraffin. 

Phrase: "The pancreas of adult NMRI mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1518865:Mouse Pancreas [Tissue]
   753   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   753   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "embedded in paraffin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.43: Immunodetection (peroxidase-diaminobenzidine technique) of insulin or SERCA3 was performed on serial sections, pretreated (SERCA3) or not (insulin) with microwaves, using a monoclonal anti-insulin antiserum (Novo Biolabs, Temecula, Denmark) or the rabbit anti-SERCA3 N89 antibody directed against a sequence corresponding to amino acid 2939 of the human SERCA3 (31). 

Phrase: "Immunodetection"

Phrase: "(peroxidase-diaminobenzidine technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]

Phrase: ")"

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "was"

Phrase: "performed on serial sections,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0031082:serial [Intellectual Product,Manufactured Object]
   770   C0884358:Performed [Functional Concept]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pretreated"

Phrase: "(SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "not (insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "with microwaves,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026051:Microwaves [Natural Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal anti-insulin antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Novo Biolabs,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "the rabbit anti-SERCA3 N89 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against a sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "corresponding to amino acid 2939 of the human SERCA3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0086418:Human [Human]
   742   C0202406:Acid [Laboratory Procedure]
   742   C1412639:SERCA3 [Gene or Genome]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: For double-fluorescent immunodetections of non-cells and SERCA3, the sections were incubated with a cocktail of monoclonal anti-glucagon (Novo Biolabs), monoclonal anti-somatostatin (Novo Biolabs), and rabbit anti-SERCA3 antisera. 

Phrase: "For double-fluorescent immunodetections"

Phrase: "of non-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "SERCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with a cocktail of monoclonal anti-glucagon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   744   C0678420:Cocktail [Food]
   744   C0746619:monoclonal [Finding]
   744   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Novo Biolabs"

Phrase: ")"

Phrase: ","

Phrase: "monoclonal anti-somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   743 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "(Novo Biolabs"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rabbit anti-SERCA3 antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.45: Detection of SERCA3 by a red immunofluorescent color (Texas Red) required a tyramine amplification step, as described elsewhere (32). 

Phrase: "Detection of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by a red immunofluorescent color"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0332575:Red color [Finding]
   913   C1260956:Red color [Qualitative Concept]
   827   C0009393:Color [Natural Phenomenon or Process]
   827   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   827   C1705245:Color [Pharmacologic Substance]
   755 E C0522507:colored [Qualitative Concept]

Phrase: "(Texas Red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0076359:Texas red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0039711:Texas [Geographic Area]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: ")"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "a tyramine amplification step,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.46: Non-cells were immunolabeled in green fluorescent color (fluorescein isothiocyanate). 

Phrase: "Non-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "immunolabeled in green fluorescent color"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0332583:Green color [Qualitative Concept]
           Green
   760   C0009393:Color [Natural Phenomenon or Process]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   760   C1705245:Color [Pharmacologic Substance]

Phrase: "(fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.47: Control experiments without primary antibody never showed any labeling. 

Phrase: "Control experiments without primary antibody never"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0009932:control experiments [Group]
   753   C0243148:control [Qualitative Concept]
   753   C0681814:Experiments [Research Activity]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "any labeling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.48: Animals, solutions, and preparations. 

Phrase: "Animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "solutions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.49: The SERCA3 gene contains 22 exons. 

Phrase: "The SERCA3 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "22 exons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.50: SERCA3 knockout mice (SERCA3 -/-) were generated previously by disrupting exon 5 (29). 

Phrase: "SERCA3 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "previously by disrupting exon 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0332454:disrupting [Qualitative Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.51: Age- (48 months) and sex-matched homozygous wild-type (SERCA3 +/+) and SERCA3 knockout mice (SERCA3 -/-) were used. 

Phrase: "Age- (48 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510828:Age-Months [Organism Attribute]
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "sex-matched homozygous wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1883559:Wild Type [Organism Attribute]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.52: The mutant mice (25  1 g) were indistinguishable from their wild-type littermates (26  1 g) in their gross phenotype and behavior. 

Phrase: "The mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(25  1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "indistinguishable from their wild-type littermates"

Phrase: "(26  1 g) in their gross phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   748   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "behavior."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.53: To evaluate glucose homeostasis of the mice, blood glucose was measured (glucometer; Bayer, Zurich) after 24 h of food deprivation and again 1 and 3 h after ad libitum refeeding. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "glucose homeostasis of the mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1326961:glucose homeostasis [Physiologic Function]
   760   C0019868:Homeostasis [Biologic Function]

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(glucometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0472226:Glucometer [Medical Device]

Phrase: "; Bayer,"

Phrase: "Zurich"

Phrase: ")"

Phrase: "after 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of food deprivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016464:Food Deprivation [Research Activity]
  1000   C1384607:Food deprivation [Finding]
   861   C0016452:Food [Food]
   861   C0871712:Deprivation [Qualitative Concept]

Phrase: "and"

Phrase: "again 1"

Phrase: "and"

Phrase: "3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after"

Phrase: "ad libitum refeeding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1879743:ad libitum [Qualitative Concept]
Processing 00000000.tx.54: One week later, the same animals were fasted again, and blood glucose was measured after 24, 25, and 27 h of fasting. 

Phrase: "One week later,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332174:/week [Temporal Concept]
   827   C0439230:week [Temporal Concept]

Phrase: "the same animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "again,"

Phrase: "and"

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured after 24,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "25,"

Phrase: "and"

Phrase: "27 h of fasting."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.55: Plasma insulin was measured as described (33). 

Phrase: "Plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.56: The medium used for the isolation of pancreatic islets and for [Ca2+]c and insulin secretion experiments was a bicarbonate-buffered solution (21). 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "used for the isolation of pancreatic islets"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   757   C1524063:Use of [Functional Concept]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0204727:Isolation [Therapeutic or Preventive Procedure]
   748   C0205409:Isolation [Functional Concept]
   748   C0220862:isolation [Laboratory Procedure]
   748   C1273517:used [Finding]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "insulin secretion experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "was"

Phrase: "a bicarbonate-buffered solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.57: When the concentration of KCl was increased, that of NaCl was decreased accordingly. 

Phrase: "When"

Phrase: "the concentration of KCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "that of NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "accordingly."
Processing 00000000.tx.58: Ca2+-free solutions were prepared by substituting MgCl2 for CaCl2 and were supplemented with 2 mmol/l EGTA. 

Phrase: "Ca2+-free solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared by substituting MgCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
   737   C1521827:Prepare [Functional Concept]

Phrase: "for CaCl2"

Phrase: "and"

Phrase: "were"

Phrase: "supplemented with 2 mmol/l EGTA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439190:MMOLE [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.59: Islets were obtained by collagenase digestion of the pancreas, and clusters were prepared by dispersion of islet cells in a Ca2+-free medium (34). 

Phrase: "Islets"

Phrase: "were"

Phrase: "obtained by collagenase digestion of the pancreas,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0012238:Digestion [Organism Function]
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   748   C1301820:Obtained [Functional Concept]
   748   C2349986:Digestion [Research Activity]
   714 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "were"

Phrase: "prepared by dispersion of islet cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   756 E C1522529:Islet Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0332624:Dispersion [Spatial Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1521827:Prepare [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in a Ca2+-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.60: Islets were cultered for 1 or 2 days, and cell clusters for 2 days in RPMI 1640 medium containing 10 mmol/l glucose. 

Phrase: "Islets"

Phrase: "were"

Phrase: "cultered for 1"

Phrase: "or"

Phrase: "2 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "clusters for 2 days"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439228:days [Temporal Concept]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "in RPMI 1640 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.61: Semiquantitative radioactive RT-PCR analysis of SERCA2 and SERCA3 mRNA. 

Phrase: "Semiquantitative radioactive RT-PCR analysis of SERCA2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0200931:PCR analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0677874:pCR [Finding]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "SERCA3 mRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.62: Islet total RNA was extracted, quantified, and reverse transcribed in cDNA as described (26). 

Phrase: "Islet total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: ","

Phrase: "quantified"

Phrase: ","

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed in cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.63: The sense (5'-GTC ATC ATG CTA ATC CTT GTG GC-3') and antisense (5'-GGG GGT CTG GAA TGG CA-3') primers for amplification of mouse SERCA3 mRNA (nucleotides 277592 of the cDNA, Genbank accession nos. U49393 and U49394) were chosen on opposite sides of the 84-bp region deleted in SERCA3 -/- mice (29), giving products of 316 and 232 bp in wild-type and knockout mice, respectively. 

Phrase: "The sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "(5'-GTC ATC ATG CTA ATC CTT GTG GC-3'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0040405:ctt [Diagnostic Procedure]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C3537453:GC [Gene or Genome]
   790   C3540513:CTA [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "antisense"

Phrase: "(5'-GGG GGT CTG GAA TGG CA-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0179630:CTG [Medical Device]
   793   C0439084:>5 [Quantitative Concept]
   793   C0728893:+5 [Quantitative Concept]
   793   C1414899:GAA [Gene or Genome]
   793   C1415053:GGT [Gene or Genome]
   793   C1705968:CTG [Quantitative Concept]

Phrase: ")"

Phrase: "primers for amplification of mouse SERCA3 mRNA (nucleotides 277592 of the cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Genbank accession nos. U49393"

Phrase: "and"

Phrase: "U49394"

Phrase: ")"

Phrase: "were"

Phrase: "chosen on opposite sides of the 84-bp region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1521805:Opposite [Spatial Concept]
   742   C1707391:Chosen [Activity]
   708   C0441987:Side [Spatial Concept]

Phrase: "deleted in SERCA3 -/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1880274:Deleted [Activity]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "products of 316"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1514468:Products [Entity]
   756 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "232 bp in wild-type"

Phrase: "and"

Phrase: "knockout mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206745:Knock-out Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "respectively."
Processing 00000000.tx.64: The sense (5'-GGC TTT TAC AGG GCG AGA GT-3') and antisense (5'-ACC AGA TTG ACC CAG AGT AAC TG-3') primers for mouse SERCA2 were chosen in a region common to both a and b isoforms (from nucleotides 531 in exon 2 to nucleotide 949 in exon 4 of SERCA2 mRNA, Genbank accession no. AJ131870), giving rise to a product of 441 bp. 

Phrase: "The sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "(5'-GGC TTT TAC AGG GCG AGA GT-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1415027:Ggc [Gene or Genome]
   791   C1883257:TAC [Therapeutic or Preventive Procedure]
   791   C2962221:TAC [Pharmacologic Substance]
   791   C2986848:TAC [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "antisense"

Phrase: "(5'-ACC AGA TTG ACC CAG AGT AAC TG-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   790   C0282160:ACC [Congenital Abnormality]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C3541413:ACC [Gene or Genome]

Phrase: ")"

Phrase: "primers for mouse SERCA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "chosen in a region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C1707391:Chosen [Activity]

Phrase: "common to both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205214:Common [Quantitative Concept]
   790   C1522138:Common [Functional Concept]
   790   C3245511:common [Intellectual Product]

Phrase: "a"

Phrase: "and"

Phrase: "b isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "from nucleotides 531"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in exon 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to nucleotide 949"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of SERCA2 mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Genbank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AJ131870"

Phrase: ")"

Phrase: ","

Phrase: "giving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to a product of 441 bp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C0439776:BP rise [Spatial Concept]
Processing 00000000.tx.65: SERCA3 cDNA was amplified in duplex with cyclophilin as internal control gene (for primers, see ref. 26). 

Phrase: "SERCA3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified in duplex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0444916:Duplex [Spatial Concept]

Phrase: "with cyclophilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136073:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0917877:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1325303:cyclophilin [Molecular Function]

Phrase: "as internal control gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Gene [Gene or Genome]
   734   C0597937:internal control [Mental Process]

Phrase: "("

Phrase: "for primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "ref. 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.66: Semiquantitative radioactive PCRs were performed as previously described (26), except that the thermal cycle profile was a 10-min denaturing step at 94C followed by 22 cycles (1-min steps at 94C, 60C, and 72C each) and a final extension step of 10 min at 72C. 

Phrase: "Semiquantitative radioactive PCRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   793   C0677874:pCR [Finding]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the thermal cycle profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "a 10-min denaturing step at 94C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "followed by 22 cycles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737   C1511572:Cycle [Temporal Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(1-min steps at 94C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C1301776:Step 1 [Functional Concept]
   760   C1261552:steps [Conceptual Entity]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726 E C2825408:Step [Manufactured Object]

Phrase: "60C,"

Phrase: "and"

Phrase: "72C"

Phrase: "each"

Phrase: ")"

Phrase: "and"

Phrase: "a final extension step of 10 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "at 72C."
Processing 00000000.tx.67: Measurements of [Ca2+]c and insulin secretion. 

Phrase: "Measurements of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.68: [Ca2+]c was measured at 37C in cultured islets or clusters of cells loaded with fura-PE3/AM (Teflabs, Austin, TX) as previously described (21). 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "measured at 37C"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "in cultured islets"

Phrase: "or"

Phrase: "clusters of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   790   C0007634:Cells [Cell]
   790   C1555715:Cluster [Idea or Concept]
   790   C1704332:Cluster [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "loaded with fura-PE3/AM (Teflabs,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0386750:fura-PE3 [Organic Chemical,Pharmacologic Substance]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0605411:austin [Organic Chemical]

Phrase: "TX)"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.69: When needed, 1 mol/l TG was added to the loading solution. 

Phrase: "When"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: ","

Phrase: "1 mol/l TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was"

Phrase: "added to the loading solution."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1524062:Added [Functional Concept]
   760   C1708715:Loading [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]
   726 E C1883712:Add [Functional Concept]
Processing 00000000.tx.70: Insulin secretion was measured in a perifusion system using batches of 15 islets (35). 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in a perifusion system"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0444706:Measured [Qualitative Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "batches of 15 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1550176:Batch [Idea or Concept]
   770   C1948031:Batch [Quantitative Concept]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.71: Presentation of the results. 

Phrase: "Presentation of the results."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.72: The experiments are illustrated by traces that are means  SE or by representative traces of results obtained with the indicated number of islets or clusters of islet cells from at least three different cultures, or with the indicated number of mice. 

Phrase: "The experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "illustrated by traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0442822:Trace [Quantitative Concept]
   756   C1524031:Trace [Qualitative Concept]
   756   C1883002:Trace [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "means  SE"

Phrase: "or by representative traces of results"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C1882932:Representative [Activity]
   719   C0442822:Trace [Quantitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1524031:Trace [Qualitative Concept]
   719   C1546471:Result [Idea or Concept]
   719   C1883002:Trace [Functional Concept]
   719   C2825142:Result [Finding]

Phrase: "obtained with the indicated number of islets"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1301820:Obtained [Functional Concept]
   748   C1444656:Indicated [Finding]
   714 E C1706701:Obtain [Activity]

Phrase: "or"

Phrase: "clusters of islet cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "from"

Phrase: "at least three different cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "or with the indicated number of mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1444656:Indicated [Finding]
Processing 00000000.tx.73: The statistical significance of differences between means was assessed by unpaired or paired Students t test as appropriate. 

Phrase: "The statistical significance of differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "between means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by unpaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516048:Assessed [Activity]
   790   C2700112:Unpaired [Qualitative Concept]

Phrase: "or"

Phrase: "paired Students t test as appropriate."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   820   C1709451:Paired t-Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:Students [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   719 E C1551041:student [Idea or Concept]
   719 E C1552573:student [Intellectual Product]
Processing 00000000.tx.74: Differences between means were considered significant at P < 0.05.  

Phrase: "Differences between means"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant at P < 0.05."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.75: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Immunolocalization of SERCA3. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Immunolocalization of SERCA3."
Processing 00000000.tx.76: Immunodetection of SERCA3 revealed a strong labeling in islets, but no staining in the exocrine pancreas (Fig. 1A). 

Phrase: "Immunodetection of SERCA3"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a strong labeling in islets,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "but"

Phrase: "no staining in the exocrine pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.77: The close similarity of the immunostaining pattern of serial sections for SERCA3 (Fig. 1A) and insulin (Fig. 1B) indicated that SERCA3 is present in -cells. 

Phrase: "The close similarity of the immunostaining pattern of serial sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similarity [Qualitative Concept]

Phrase: "for SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "present in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.78: A minority of islet cells, often localized at the periphery and hence thought to be non-cells, did not display SERCA3 immunoreactivity (arrows in Fig. 1A and B). 

Phrase: "A minority of islet cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026192:Minority [Population Group]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "localized at the periphery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "hence"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "non-cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "SERCA3 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "(arrows in Fig. 1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336721:arrows [Manufactured Object]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.79: This was confirmed by double immunodetection of non-cells and SERCA3, which unequivocally revealed that glucagon- or somatostatin-secreting cells were not immunoreactive for SERCA3 (Fig. 1CH ). 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed by double immunodetection of non-cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0007634:Cells [Cell]
   748   C0205173:Double [Functional Concept]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1518422:Non [Functional Concept]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1456348:Confirm [Qualitative Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "SERCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "which unequivocally"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "somatostatin-secreting cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0524984:Somatostatin-Secreting Cells [Cell]
           Somatostatin Cells
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "not immunoreactive for SERCA3"

Phrase: "(Fig. 1CH"

Phrase: ")."
Processing 00000000.tx.80: SERCA3 expression is thus limited to -cells. 

Phrase: "SERCA3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "thus"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "to -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.81: View larger version (102K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(102K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.83: Immunolocalization of SERCA3 in the mouse pancreas. 

Phrase: "Immunolocalization of SERCA3"

Phrase: "in the mouse pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518865:Mouse Pancreas [Tissue]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.84: A and B: Immunodetection of SERCA3 (A) and insulin (B) on serial sections suggested that SERCA3 and insulin immunoreactivity have a similar localization within the islet. 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Immunodetection of SERCA3"

Phrase: "(A)"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(B) on serial sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "insulin immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "have"

Phrase: "a similar localization within the islet."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.85: Some peripheral islet cells (arrows) and the exocrine tissue were not stained. 

Phrase: "Some peripheral islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "the exocrine tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "stained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.86: (CH) Double immunodetections of SERCA3 in red and glucagon plus somatostatin in green (non-cells) on the same section. 

Phrase: "(CH)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558269:Ch. [Professional or Occupational Group]
  1000   C1552984:[Ch] [Quantitative Concept]

Phrase: "Double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "immunodetections of SERCA3"

Phrase: "in red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "glucagon plus somatostatin in green"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(non-cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "on the same section."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]
Processing 00000000.tx.87: Red and green colors were digitally separated in C, D, F, and G, whereas they were digitally combined in E and H. 

Phrase: "Red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "green colors"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0332583:Green color [Qualitative Concept]
   861   C0009393:Colors [Natural Phenomenon or Process]
   827 E C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   827 E C1705245:Color [Pharmacologic Substance]
   777 E C0522507:colored [Qualitative Concept]

Phrase: "were"

Phrase: "digitally"

Phrase: "separated in C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "F,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "they"

Phrase: "were"

Phrase: "digitally"

Phrase: "combined in E"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205195:Combined [Qualitative Concept]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.88: In E and H, a yellow color was seen in restricted areas, where the cytoplasms of red- and green-labeled cells slightly overlapped due to the thickness of the section. 

Phrase: "In E"

Phrase: "and"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "a yellow color"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0221205:Yellow color [Qualitative Concept]
  1000   C0863146:Yellow color [Qualitative Concept]
   861   C0009393:Color [Natural Phenomenon or Process]
   861   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   861   C1705245:Color [Pharmacologic Substance]
   789 E C0522507:colored [Qualitative Concept]

Phrase: "was"

Phrase: "seen in restricted areas,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205146:areas [Spatial Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0443288:Restricted [Functional Concept]
   767   C0150136:Area restriction [Therapeutic or Preventive Procedure]
   737 E C0017446:Area [Geographic Area]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "where"

Phrase: "the cytoplasms of red-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasms [Cell Component]

Phrase: "and"

Phrase: "green-labeled cells slightly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "overlapped due to the thickness of the section."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0185027:overlapped [Therapeutic or Preventive Procedure]
   744   C0205155:Section [Spatial Concept]
   744   C1280412:Thickness [Qualitative Concept]
   744   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   744   C1522472:Section [Substance]
   744   C1552923:Section [Quantitative Concept]
   744   C1705191:Section [Physical Object]
   744   C3146286:Due [Idea or Concept]
   711 E C1948020:Overlap [Conceptual Entity]
Processing 00000000.tx.89: However, no overlapping of the two colors was ever observed in whole cells, indicating that non-cells of the islet do not express SERCA3. 

Phrase: "However,"

Phrase: "no overlapping of the two colors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   753   C1948020:Overlapping [Conceptual Entity]

Phrase: "was"

Phrase: "ever"

Phrase: "observed in whole cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444667:Whole [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that non-cells of the islet"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   783   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   767 E C1522529:Islet Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.90: Original magnifications: A and B: x150; 

Phrase: "Original magnifications"

Phrase: ":"

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "x150"

Phrase: ";"
Processing 00000000.tx.91: CE: x500; 

Phrase: "CE"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "x500"

Phrase: ";"
Processing 00000000.tx.92: FH: x1,000.  

Phrase: "FH"

Phrase: ":"

Phrase: "x1,"

Phrase: "000."
Processing 00000000.tx.93: RT-PCR experiments. 

Phrase: "RT-PCR experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.94: The expression of SERCA3 and SERCA2 in islet cells was assessed by RT-PCR on total RNA extracted from SERCA3 +/+ and SERCA3 -/- islets (Fig. 2). 

Phrase: "The expression of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "SERCA2 in islet cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0916183:serca2 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1412638:SERCA2 [Gene or Genome]

Phrase: "was"

Phrase: "assessed by RT-PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0040649:Transcription [Genetic Function]
   753   C0443286:Reaction [Functional Concept]
   753   C0677874:pCR [Finding]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1516048:Assessed [Activity]
   753   C1555029:Reverse [Idea or Concept]

Phrase: "on total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from SERCA3 +/+"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C1412639:SERCA3 [Gene or Genome]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.95: As expected, the size of SERCA3 amplicon from SERCA3 -/- mice was smaller than that of SERCA3 +/+ mice (Fig. 2B). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the size of SERCA3 amplicon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "from SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "smaller than that of SERCA3 +/+ mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.96: This difference in size results from the excision of the last 84 nucleotides in exon 5, which impairs the pump activity of SERCA3 (29). 

Phrase: "This difference in size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1268722:Difference in size [Finding]
           size difference
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "results from the excision of the last 84 nucleotides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0015252:excision [Therapeutic or Preventive Procedure]
   742   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0728940:Excision [Therapeutic or Preventive Procedure]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "in exon 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "impairs"

Phrase: "the pump activity of SERCA3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1153663:pump activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.97: Under semiquantitative PCR conditions, the levels of the mutated SERCA3 mRNA of SERCA3 -/- islets were much lower than those of the wild-type SERCA3 mRNA of SERCA3 +/+ islets (Fig. 2A). 

Phrase: "Under semiquantitative PCR conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the levels of the mutated SERCA3 mRNA of SERCA3 -/- islets"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "much lower than those of the wild-type SERCA3 mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0441994:Lower [Spatial Concept]
   739   C1548802:Lower [Body Location or Region]
   739   C2003888:Lower [Activity]

Phrase: "of SERCA3 +/+ islets"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.98: However, the expression level of SERCA2 mRNA (presumably SERCA2b) relative to the control mRNA cyclophilin in SERCA3 -/- islets was 98.7% of that observed in SERCA3 +/+ islets (n = 2). 

Phrase: "However,"

Phrase: "the expression level of SERCA2 mRNA (presumably SERCA2b"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C3244092:expression level [Idea or Concept]
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "relative to the control mRNA cyclophilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in SERCA3 -/- islets"

Phrase: "was"

Phrase: "98.7% of that"

Phrase: "observed in SERCA3 +/+ islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]

Phrase: "(n = 2)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.99: This suggests that the absence of SERCA3 is not compensated for by an overexpression of SERCA2 in islets. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the absence of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compensated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205432:Compensated [Qualitative Concept]

Phrase: "by an overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of SERCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916183:serca2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412638:SERCA2 [Gene or Genome]

Phrase: "in islets."
Processing 00000000.tx.100: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.102: Comparison of SERCA2 and SERCA3 mRNA levels by RT-PCR in isolated islets from SERCA3 +/+ (WT) and SERCA3 -/- (KO) mice. 

Phrase: "Comparison of SERCA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "SERCA3 mRNA levels by RT-PCR"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1158816:mRNA transcription [Genetic Function]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in isolated islets"

Phrase: "from SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(WT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "and"

Phrase: "SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(KO) mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.103: A: After reverse transcription (RT+) of islet total RNA, SERCA3 and SERCA2 cDNAs were amplified for 22 cycles under semiquantitative conditions. 

Phrase: "A"

Phrase: ":"

Phrase: "After"

Phrase: "reverse transcription (RT+) of islet total RNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0040649:Transcription [Genetic Function]
   753   C1555029:Reverse [Idea or Concept]

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA2 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "amplified for 22 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "under semiquantitative conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.104: Cyclophilin was used as an internal control gene and amplified in duplex with SERCA3. 

Phrase: "Cyclophilin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0136073:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0917877:Cyclophilin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1325303:cyclophilin [Molecular Function]

Phrase: "was"

Phrase: "used as an internal control gene"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0597937:internal control [Mental Process]
   753   C0017337:Gene [Gene or Genome]
   753   C0205102:Internal [Spatial Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1550141:Control [Substance]
   753   C1553872:Internal [Intellectual Product]
   753   C1619620:Internal [Intellectual Product]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "amplified in duplex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0444916:Duplex [Spatial Concept]

Phrase: "with SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.105: SERCA2 mRNA expression was not affected by SERCA3 ablation. 

Phrase: "SERCA2 mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by SERCA3 ablation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0392760:Affected [Functional Concept]
   770   C0547070:Ablation [Therapeutic or Preventive Procedure]
   770   C1261381:ablation [Therapeutic or Preventive Procedure]
   770   C1314939:Affected [Functional Concept]
   770   C1412639:SERCA3 [Gene or Genome]
   737 E C0001721:Affect [Mental Process]
Processing 00000000.tx.106: Compared with the 316-bp product in islets from wild-type mice, the shorter SERCA3 amplicon in SERCA3 -/- islets only gave a faint band under these conditions. 

Phrase: "Compared with the 316-bp product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "in islets"

Phrase: "from wild-type mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "the shorter SERCA3 amplicon in SERCA3 -/- islets only"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a faint band under these conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]
Processing 00000000.tx.107: B: SERCA3 cDNA was amplified for 40 cycles to confirm the presence and size of the shorter SERCA3 amplicon in islets from knockout mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "SERCA3 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "amplified for 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439509:/40 [Temporal Concept]

Phrase: "cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "size of the shorter SERCA3 amplicon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "in islets"

Phrase: "from knockout mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206745:Knock-out Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.108: No PCR products were amplified when reverse transcriptase was omitted from the reverse transcription reaction (RT-). 

Phrase: "No PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "amplified"

Phrase: "when"

Phrase: "reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: "was"

Phrase: "omitted from the reverse transcription reaction (RT-)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0040649:Transcription [Genetic Function]
   753   C0443286:Reaction [Functional Concept]
   753   C0750563:omitted [Idea or Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.109: The results of both panels are representative of experiments performed on islets from two mice.  

Phrase: "The results of both panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882932:Representative [Activity]

Phrase: "performed on islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from two mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.110: Evaluation of the role of SERCA3 at basal [Ca2+]c. 

Phrase: "Evaluation of the role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.111: During perifusion of the islets with a glucose-free medium or a medium containing glucose and the ATP-sensitive K+ channel opener diazoxide, [Ca2+]c was low and stable. 

Phrase: "During perifusion"

Phrase: "of the islets"

Phrase: "with a glucose-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "or"

Phrase: "a medium containing glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "the ATP-sensitive K+ channel opener diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   743 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "stable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.112: There was no significant difference between basal [Ca2+]c in SERCA3 +/+ and SERCA3 -/- islets in all experimental series (pooled data of G0, G3, G0 plus diazoxide, G10 plus diazoxide, and G20 plus diazoxide: 99  3 nmol/l, n = 38, in SERCA3 +/+ islets vs. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference between basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA3 -/- islets in all experimental series"

Phrase: "(pooled data of G0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "G3,"

Phrase: "G0 plus diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   771 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "G10 plus diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   771 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "G20 plus diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   771 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "99  3 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "in SERCA3 +/+ islets"

Phrase: "vs."
Processing 00000000.tx.113: 94  3 nmol/l, n = 38, in SERCA3 -/- islets). 

Phrase: "94  3 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "in SERCA3 -/- islets"

Phrase: ")."
Processing 00000000.tx.114: Pretreatment of the islets with TG did not increase basal [Ca2+]c in SERCA3 +/+ (106  7 nmol/l, n = 8) and SERCA3 -/- islets (78  6 nmol/l, n = 7). 

Phrase: "Pretreatment of the islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412639:SERCA3 [Gene or Genome]

Phrase: "(106  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "(78  6 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.115: This suggests that basal [Ca2+]c is mainly set by mechanisms other than the SERCAs. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "set by mechanisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0441712:Mechanisms [Functional Concept]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "other than the SERCAs."
Processing 00000000.tx.116: We next evaluated the role of SERCA3 in glucose-stimulated Ca2+ uptake by the ER. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in glucose-stimulated Ca2+ uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1159527:glucose uptake [Cell Function]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "by the ER."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.117: Switching from a glucose-free medium to a medium containing 15 mmol/l glucose induced an initial decrease in [Ca2+]c that preceded a [Ca2+]c rise in SERCA3 +/+ islets (Fig. 3A). 

Phrase: "Switching from a glucose-free medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0009458:Medium [Intellectual Product]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332296:free [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719   C1707719:Switch [Manufactured Object]

Phrase: "to a medium containing 15 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an initial decrease in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "that"

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "a [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise in SERCA3 +/+ islets"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.118: This drop is attributed to Ca2+ uptake by the ER because it was completely prevented by TG. 

Phrase: "This drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]

Phrase: "is"

Phrase: "attributed to Ca2+ uptake"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "because"

Phrase: "it"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented by TG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   756   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.119: Glucose also transiently lowered [Ca2+]c in SERCA3 -/- islets (Fig. 3B). 

Phrase: "Glucose also transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in SERCA3 -/- islets"

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.120: The amplitude of this initial fall was similar in SERCA3 +/+ (19  2 nmol/l, n = 9) and SERCA3 -/- islets (15  1 nmol/l, n = 9). 

Phrase: "The amplitude of this initial fall"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "similar in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "(19  2 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "(15  1 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.121: Similar observations were made when the experiments were performed in the presence of diazoxide (not shown). 

Phrase: "Similar observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "when"

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in the presence of diazoxide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.124: SERCA3 does not mediate the initial [Ca2+]c decrease induced by glucose. 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205265:Initial [Temporal Concept]
  1000   C1279901:Initial [Qualitative Concept]
  1000   C1555582:Initial [Idea or Concept]
  1000   C1705685:INITIAL [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "induced by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.125: Isolated islets from SERCA3 +/+ (A) or SERCA3 -/- (B) mice were pretreated (dotted line) or not (solid line) with 1 mol/l TG during loading with fura-PE3. 

Phrase: "Isolated islets from SERCA3 +/+"

Phrase: "(A)"

Phrase: "or"

Phrase: "SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(B) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "pretreated"

Phrase: "(dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "not (solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "with 1 mol/l TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "during loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]

Phrase: "with fura-PE3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0386750:fura-PE3 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.126: After an initial perifusion without glucose (G0), they were perifused with a medium containing 15 mmol/l glucose (G15), as indicated on the top of the panels. 

Phrase: "After an initial perifusion"

Phrase: "without glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G0"

Phrase: ")"

Phrase: ","

Phrase: "they"

Phrase: "were"

Phrase: "perifused with a medium containing 15 mmol/l glucose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0009458:Medium [Intellectual Product]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0332256:Containing [Functional Concept]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]

Phrase: "(G15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419301:G15 [Gene or Genome]
  1000   C1709809:G15 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "indicated on the top of the panels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1704458:Top [Spatial Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.127: The traces show mean changes () around basal [Ca2+]c in the absence of glucose. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mean changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "around basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the absence of glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.128: Basal levels were 104  9 nmol/l, n = 9 (A, solid line); 

Phrase: "Basal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "104  9 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A,"

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.129: 111  13 nmol/l, n = 3 (A, dotted line); 

Phrase: "111  13 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A,"

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.130: 80  7 nmol/l, n = 9 (B, solid line); 

Phrase: "80  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.131: and 70  11 nmol/l, n = 3 (B, dotted line).  

Phrase: "and"

Phrase: "70  11 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: The ER comprises Ins(1,4,5) P3 (IP3)-sensitive and -insensitive Ca2+ stores that are both refilled by SERCAs during exposure to glucose (19,36,37). 

Phrase: "The ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "comprises Ins(1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1414685:INS-1 [Gene or Genome]
   882   C3538717:INS-1 [Gene or Genome]
   790   C2700400:Comprise [Activity]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "P3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: "(IP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: ")-"

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "and -"

Phrase: "insensitive Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1698986:Store [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "both"

Phrase: "refilled by SERCAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0807726:refilled [Idea or Concept]

Phrase: "during exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(19,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.133: ACh mobilizes Ca2+ from IP3-sensitive stores, whereas TG mobilizes Ca2+ from both stores (19,36). 

Phrase: "ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "mobilizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:mobilize [Therapeutic or Preventive Procedure]
  1000   C0578718:Mobilizes [Finding]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from IP3-sensitive stores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1698986:Store [Functional Concept]

Phrase: "whereas"

Phrase: "TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "mobilizes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:mobilize [Therapeutic or Preventive Procedure]
  1000   C0578718:Mobilizes [Finding]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from both stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "(19,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.134: To evaluate the role of SERCA3 in the replenishment of these Ca2+ stores and the maintenance of their Ca2+ content at basal [Ca2+]c, islets and clusters of cells were initially perifused with a medium containing Ca2+, diazoxide, and 10 or 20 mmol/l glucose, which maximally stimulates Ca2+ uptake by the ER (19,38). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the replenishment"

Phrase: "of these Ca2+ stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "and"

Phrase: "the maintenance of their Ca2+ content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "islets"

Phrase: "and"

Phrase: "clusters of cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   790   C0007634:Cells [Cell]
   790   C1555715:Cluster [Idea or Concept]
   790   C1704332:Cluster [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "perifused with a medium containing Ca2+,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "diazoxide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10"

Phrase: "or"

Phrase: "20 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "which maximally"

Phrase: "stimulates"

Phrase: "Ca2+ uptake by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(19,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.135: They were then perifused for 5 (islets) or 8 min (clusters of cells) with a Ca2+-free medium supplemented with 2 mmol/l EGTA to prevent Ca2+ influx. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "perifused for 5"

Phrase: "(islets"

Phrase: ")"

Phrase: "or"

Phrase: "8 min (clusters of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: ")"

Phrase: "with a Ca2+-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 2 mmol/l EGTA to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1532563:mmol/L [Quantitative Concept]
   748   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0439190:MMOLE [Quantitative Concept]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "Ca2+ influx."
Processing 00000000.tx.136: Subsequent addition of ACh triggered a large transient rise in [Ca2+]c in islets (Fig. 4A) and clusters (Fig. 4B). 

Phrase: "Subsequent addition of ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "a large transient rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in islets"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: In clusters, addition of TG 8 min after removal of ACh induced a small [Ca2+]c elevation that reflects release of residual Ca2+, not mobilized by ACh (right side of Fig. 4B). 

Phrase: "In clusters,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "addition of TG 8 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "after removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "that"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "release of residual Ca2+,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "mobilized by ACh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0185112:mobilized [Therapeutic or Preventive Procedure]
   790   C0578718:mobilized [Finding]

Phrase: "(right side of Fig. 4B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205090:Right side [Spatial Concept]
   760   C0441987:Side [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.138: The magnitude of the [Ca2+]c rises induced by ACh and TG was similar in SERCA3 +/+ and SERCA3 -/- islet cells. 

Phrase: "The magnitude of the [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "]c rises"

Phrase: "induced by ACh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was"

Phrase: "similar in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "SERCA3 -/- islet cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.139: The effect of 100 mol/l ACh on [Ca2+]c was also tested in islets perifused with a medium containing Ca2+, 20 mmol/l glucose, and 250 mol/l diazoxide. 

Phrase: "The effect of 100 mol/l ACh on [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "tested in islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392366:tested [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "perifused with a medium containing Ca2+,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "20 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "250 mol/l diazoxide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   756 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.140: The amplitude of the mobilization of Ca2+ was again similar in SERCA3 +/+ (189  12 nmol/l, n = 3) and SERCA3 -/- islets (202  28 nmol/l, n = 3). 

Phrase: "The amplitude of the mobilization of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "again similar in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(189  12 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "(202  28 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: These results suggest that the IP3-sensitive and -insensitive Ca2+ pools of the ER do not require SERCA3 activity to be filled with Ca2+ during glucose stimulation and to retain Ca2+ when [Ca2+]c is low. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the IP3-sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "and -"

Phrase: "insensitive Ca2+ pools of the ER"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0337051:pools [Geographic Area]
   714 E C1509144:pool [Clinical Attribute]
   714 E C2349200:Pool [Functional Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "SERCA3 activity to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "be"

Phrase: "filled with Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1708059:Filled [Activity]

Phrase: "during glucose stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "when"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]
Processing 00000000.tx.142: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 4. 

Phrase: "4."
Processing 00000000.tx.144: SERCA3 is not required for refilling IP3-sensitive and -insensitive Ca2+ pools in mouse islets. 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for refilling IP3-sensitive"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
   760   C0332324:Sensitive [Functional Concept]
   760   C0807726:refilling [Idea or Concept]
   760   C1514873:Required [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]
   760   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "and -"

Phrase: "insensitive Ca2+ pools in mouse islets."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0337051:pools [Geographic Area]
   719 E C1509144:pool [Clinical Attribute]
   719 E C2349200:Pool [Functional Concept]
Processing 00000000.tx.145: Before the recording, islets (A) or clusters of islet cells (B) were bathed in a medium containing 2.5 mmol/l Ca2+, 100 mol/l diazoxide (Dz), and 10 (G10) or 20 mmol/l glucose (G20), respectively. 

Phrase: "Before the recording,"

Phrase: "islets"

Phrase: "(A)"

Phrase: "or"

Phrase: "clusters of islet cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "bathed in a medium containing 2.5 mmol/l Ca2+,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C1532563:mmol/L [Quantitative Concept]
   739   C0009458:Medium [Intellectual Product]
   739   C0150141:bathed [Therapeutic or Preventive Procedure]
   739   C0332256:Containing [Functional Concept]
   739   C0439190:MMOLE [Quantitative Concept]
   739   C0439536:Medium [Quantitative Concept]
   739   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C1705217:Medium [Substance]
   739   C2700400:Containing [Activity]
   739   C3244283:medium [Intellectual Product]

Phrase: "100 mol/l diazoxide (Dz),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   756 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10"

Phrase: "(G10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1538148:G10 [Gene or Genome]
  1000   C1823197:G10 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1540229:G20 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.146: They were then perifused with a Ca2+-free medium supplemented with 2 mmol/l EGTA for 5 (islets) or 8 min (clusters of cells) before addition of 100 mol/l ACh. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "perifused with a Ca2+-free medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0332296:free [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 2 mmol/l EGTA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439190:MMOLE [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "for 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(islets"

Phrase: ")"

Phrase: "or"

Phrase: "8 min (clusters of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: ")"

Phrase: "before"

Phrase: "addition of 100 mol/l ACh."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]
Processing 00000000.tx.147: In clusters only, 1 mol/l TG was added as indicated. 

Phrase: "In clusters only,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555715:Cluster [Idea or Concept]
   827   C1704332:Cluster [Quantitative Concept]

Phrase: "1 mol/l TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.148: The traces show mean changes () around basal [Ca2+]c levels at the beginning of the recording. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mean changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "around basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c levels at the beginning of the recording."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.149: Basal levels were 117  8 nmol/l, n = 5 (A, solid line); 

Phrase: "Basal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "117  8 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A,"

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.150: 98  7 nmol/l, n = 6 (A, dotted line); 

Phrase: "98  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A,"

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.151: 41  6 nmol/l, n = 4 (B, solid line); 

Phrase: "41  6 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.152: and 36  9 nmol/l, n = 4 (B, dotted line).  

Phrase: "and"

Phrase: "36  9 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.153: Role of SERCA3 at elevated [Ca2+]c. 

Phrase: "Role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "at elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.154: The role of SERCA3 was next evaluated under conditions where [Ca2+]c was transiently elevated by depolarizing the plasma membrane with 45 mmol/l K+ to stimulate Ca2+ influx through voltage-dependent Ca2+ channels. 

Phrase: "The role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "was"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated under conditions where"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220825:Evaluated [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "transiently"

Phrase: "elevated by depolarizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "the plasma membrane with 45 mmol/l K+ to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0007603:Plasma membrane [Cell Component]
   742   C0025255:Membrane [Tissue]
   742   C0032105:Plasma [Body Substance]
   742   C0596901:Membrane [Cell Component]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1706182:Membrane [Manufactured Object]

Phrase: "stimulate"

Phrase: "Ca2+ influx through voltage-dependent Ca2+ channels."
Processing 00000000.tx.155: Diazoxide was present throughout to prevent glucose-induced [Ca2+]c oscillations (15) and to impose similar membrane potentials in the presence and absence of TG (21). 

Phrase: "Diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "throughout to"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "impose"

Phrase: "similar membrane potentials in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025251:Membrane Potentials [Cell Function]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:potentials [Qualitative Concept]

Phrase: "and"

Phrase: "absence of TG"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.156: Depolarizing SERCA3 +/+ islets for 30 s induced a large and rapid [Ca2+]c rise followed by a slightly ascending plateau and a descending phase characterized by an initial fast component and a secondary slow decline (Fig. 5A, solid line). 

Phrase: "Depolarizing SERCA3 +/+ islets for 30 s"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise"

Phrase: "followed by a slightly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0750482:Slightly [Idea or Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "ascending"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205385:Ascending [Qualitative Concept]
  1000   C1547175:Ascending [Functional Concept]
  1000   C1962987:Ascending [Functional Concept]
   966 E C0308355:ASCEND [Organic Chemical,Pharmacologic Substance]

Phrase: "plateau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "and"

Phrase: "a descending phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "characterized by an initial fast component"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0015663:Fast [Finding]
   753   C0205265:Initial [Temporal Concept]
   753   C0449432:Component [Manufactured Object]
   753   C0456962:Fast [Qualitative Concept]
   753   C1279901:Initial [Qualitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705248:Component [Conceptual Entity]
   753   C1705685:INITIAL [Functional Concept]
   753   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "a secondary slow decline"

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: As previously reported (21), TG pretreatment increased the rising phase to the peak (P < 0.05), gave the plateau a slowly descending shape, and suppressed the secondary slow component of the recovery phase (Fig. 5A, dotted line). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "TG pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the rising phase to the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205390:Phase [Temporal Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "the plateau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2964353:Plateau [Quantitative Concept]

Phrase: "a slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "descending"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205386:Descending [Qualitative Concept]
  1000   C1547177:Descending [Qualitative Concept]

Phrase: "shape,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332479:Shape [Spatial Concept]
  1000   C0348078:shape [Qualitative Concept]
  1000   C0522512:Shape [Spatial Concept]

Phrase: "and"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the secondary slow component of the recovery phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.158: These changes have been interpreted as evidence that the ER takes up Ca2+ during the upstroke of the [Ca2+]c rise and releases it slowly when Ca2+ influx stops (21). 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "interpreted as evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332120:Evidence [Functional Concept]
   790   C1285553:interpreted [Functional Concept]

Phrase: "that"

Phrase: "the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "takes up Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C1515187:Take [Health Care Activity]

Phrase: "during the upstroke"

Phrase: "of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise"

Phrase: "and"

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "it slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "when"

Phrase: "Ca2+ influx stops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0450446:Stops [Manufactured Object]
   793 E C1947925:Stop [Activity]
   793 E C2746065:Stop [Temporal Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.159: Strikingly, the [Ca2+]c changes induced by the high K+ pulse in SERCA3 -/- islets had a similar shape to that observed in SERCA3 +/+ islets after TG pretreatment (compare Fig. 5A dotted line with Fig. 5B dotted line). 

Phrase: "Strikingly,"

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "induced by the high K+ pulse"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205250:High [Qualitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1299351:High [Qualitative Concept]
   753   C1708601:K' [Quantitative Concept]
   753   C1947910:Pulse [Phenomenon or Process]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "in SERCA3 -/- islets"

Phrase: "had"

Phrase: "a similar shape to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332479:Shape [Spatial Concept]
   760   C0348078:shape [Qualitative Concept]
   760   C0522512:Shape [Spatial Concept]

Phrase: "observed in SERCA3 +/+ islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]

Phrase: "after TG pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "dotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "line with Fig. 5B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]

Phrase: "dotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205132:Line [Spatial Concept]
  1000   C1550648:Line [Substance]
  1000   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: In contrast, TG pretreatment of SERCA3 -/- islets did not significantly change the characteristics of the [Ca2+]c rise and decrease induced by the K+ pulse (Fig. 5C). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "TG pretreatment of SERCA3 -/- islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the characteristics of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "]c rise"

Phrase: "and"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "induced by the K+ pulse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205263:Induced [Functional Concept]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1708601:K' [Quantitative Concept]
   760   C1947910:Pulse [Phenomenon or Process]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.161: These observations indicate that the difference (P < 0.05) in [Ca2+]c peak amplitude between SERCA3 +/+ and SERCA3 -/- islets, illustrated in Fig. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c peak amplitude between SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "SERCA3 -/- islets,"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.162: 5B, is due to a buffering action of the ER that is mainly mediated by SERCA3 activity. 

Phrase: "5B,"

Phrase: "is due to a buffering action of the ER"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0678226:Due to [Functional Concept]
           due
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0441472:Action [Functional Concept]
   739   C3146286:Due [Idea or Concept]
   739   C3266814:Action [Activity]
   706   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "mainly"

Phrase: "mediated by SERCA3 activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.163: They also show that a major component of the slow recovery phase observed in SERCA3 +/+ islets corresponds to the release of Ca2+ from ER Ca2+ pools that were replenished by SERCA3. 

Phrase: "They also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a major component of the slow recovery phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "observed in SERCA3 +/+ islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1441672:Observed [Functional Concept]

Phrase: "corresponds to the release of Ca2+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from ER Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "replenished by SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.164: A small contribution of SERCA2b is suggested by the minor residual slow recovery [Ca2+]c phase in SERCA3 -/- islets (Fig. 5C). 

Phrase: "A small contribution of SERCA2b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "is"

Phrase: "suggested by the minor residual slow recovery"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0026193:Minor [Population Group]
   748   C0205165:Minor [Qualitative Concept]
   748   C0237820:Recovery [Activity]
   748   C0439834:Slow [Qualitative Concept]
   748   C1555688:recovery [Idea or Concept]
   748   C1609982:Residual [Qualitative Concept]
   748   C2004454:Recovery [Organism Function]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c phase in SERCA3 -/- islets"

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.165: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.166: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.167: SERCA3 influences [Ca2+]c changes induced by a 30-s pulse of 45 mmol/l K+ in mouse islets. 

Phrase: "SERCA3 influences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0021399:influential [Idea or Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "induced by a 30-s pulse of 45 mmol/l"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   775   C2827956:mmol*s/L [Quantitative Concept]
   760   C1532563:mmol/L [Quantitative Concept]
   757   C2827891:mmol/s [Quantitative Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0232117:PULSE [Clinical Attribute]
   739   C0391850:Pulse [Physiologic Function]
   739   C0439190:MMOLE [Quantitative Concept]
   739   C1947910:Pulse [Phenomenon or Process]

Phrase: "K+ in mouse islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.168: Isolated islets from SERCA3 +/+ or SERCA3 -/- mice were pretreated or not with 1 mol/l TG during loading with fura-PE3. 

Phrase: "Isolated islets from SERCA3 +/+"

Phrase: "or"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "pretreated"

Phrase: "or"

Phrase: "not with 1 mol/l TG"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0347982:mol/L [Quantitative Concept]
   753   C0027960:Mole [Neoplastic Process]
   753   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0324740:Mole [Mammal]
   753   C0439189:Mole [Quantitative Concept]
   753   C1456781:mole [Neoplastic Process]
   753   C1518422:Not [Functional Concept]
   753   C1824986:mol [Gene or Genome]

Phrase: "during loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]

Phrase: "with fura-PE3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0386750:fura-PE3 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.169: They were then perifused throughout with a medium containing 10 mmol/l glucose (G10) and 100 mol/l diazoxide (Dz). 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "perifused"

Phrase: "throughout with a medium containing 10 mmol/l glucose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0009458:Medium [Intellectual Product]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0332256:Containing [Functional Concept]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]

Phrase: "(G10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1538148:G10 [Gene or Genome]
  1000   C1823197:G10 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "100 mol/l diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   756 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "(Dz"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.170: The K+ concentration was increased from 4.8 to 45 mmol/l when indicated by the horizontal bar. 

Phrase: "The K+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased from 4.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "to 45 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "when"

Phrase: "indicated by the horizontal bar."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205126:Horizontal [Spatial Concept]
   760   C1444656:Indicated [Finding]
Processing 00000000.tx.171: The traces show mean changes () around basal [Ca2+]c levels before the pulse of high K+. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mean changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "around basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c levels before the pulse of high K+."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.172: Basal levels were 122  7 nmol/l, n = 7 (A and B, solid line); 

Phrase: "Basal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "122  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.173: 104  7 nmol/l, n = 6 (B, dotted line and C, solid line); 

Phrase: "104  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.174: 104  9 nmol/l, n = 5 (A, dotted line); 

Phrase: "104  9 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(A,"

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.175: and 84  7 nmol/l, n = 4 (C, dotted line). 

Phrase: "and"

Phrase: "84  7 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.176: *P < 0.05 for comparisons of the mean amplitude of the high K+-induced elevation in [Ca2+]c between groups shown by dotted and solid lines.  

Phrase: "*P < 0.05 for comparisons of the mean amplitude"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0444504:Mean [Quantitative Concept]
   742   C2346753:Amplitude [Spatial Concept]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   742   C2603361:P' [Clinical Attribute]
   708   C1707455:Comparison [Activity]

Phrase: "of the high K+-induced elevation in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c between groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0441837:Group C [Classification]
   790   C1553033:[c] [Quantitative Concept]

Phrase: "shown by dotted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0872145:DOT [Therapeutic or Preventive Procedure]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "solid lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.177: Influence of SERCA3 on glucose-induced [Ca2+]c oscillations. 

Phrase: "Influence of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "on glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]
Processing 00000000.tx.178: Increasing the glucose concentration from 3 to 7 mmol/l triggered a transient rise in [Ca2+]c in all islets. 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the glucose concentration from 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0427743:Glucose concentration [Laboratory Procedure]
   806   C1287281:Glucose concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "to 7 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "triggered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032930:Trigger [Clinical Attribute]
   966   C1444748:Trigger [Qualitative Concept]

Phrase: "a transient rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "all islets."
Processing 00000000.tx.179: Thereafter, [Ca2+]c started to oscillate in 12/14 SERCA3 +/+ and 7/13 SERCA3 -/- islets and returned to basal levels in the others (Fig. 6A and B). 

Phrase: "Thereafter,"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "started"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272689:Started [Qualitative Concept]
   966 E C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "oscillate in 12/14 SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "7/13 SERCA3 -/- islets"

Phrase: "and"

Phrase: "returned to basal levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   816   C0332156:Return to [Qualitative Concept]
           Return
   770   C0205112:Basal [Spatial Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.180: In 10 mmol/l glucose, [Ca2+]c oscillations occurred in all islets. 

Phrase: "In 10 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "occurred in all islets."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1709305:Occurred [Activity]
   737 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.181: In 20 mmol/l glucose, [Ca2+]c was steadily elevated in 12/14 SERCA3 +/+ and 9/13 SERCA3 -/- islets, whereas it continued to oscillate in the others. 

Phrase: "In 20 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "steadily"

Phrase: "elevated in 12/14 SERCA3 +/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205250:Elevated [Qualitative Concept]
   760   C1412639:SERCA3 [Gene or Genome]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "9/13 SERCA3 -/- islets,"

Phrase: "whereas"

Phrase: "it"

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "oscillate in the others."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1955473:Others [Finding]
Processing 00000000.tx.182: Average [Ca2+]c, integrated over the last 5 min at each glucose concentration, was similar in both types of islets (Fig. 6C). 

Phrase: "Average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "integrated over the last 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "at each glucose concentration,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "similar in both types of islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.183: However, several features of [Ca2+]c oscillations were different. 

Phrase: "However,"

Phrase: "several features of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.184: The nadir between oscillations was more elevated in SERCA3 +/+ than SERCA3 -/- islets, in both 7 mmol/l glucose (120  4 nmol/l, n = 12 vs. 98  6 nmol/l, n = 7) and 10 mmol/l glucose (156  5 nmol/l, n = 14 vs. 119  6 nmol/l, n = 13). 

Phrase: "The nadir between oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708760:Nadir [Qualitative Concept]

Phrase: "was"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "elevated in SERCA3 +/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205250:Elevated [Qualitative Concept]
   790   C1412639:SERCA3 [Gene or Genome]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "than SERCA3 -/- islets,"

Phrase: "in both 7 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(120  4 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs. 98  6 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "10 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(156  5 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "vs. 119  6 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.185: Therefore, the difference between nadir and basal [Ca2+]c at 3 mmol/l glucose was significantly larger in SERCA3 +/+ than SERCA3 -/- islets (1 and 2 in Fig. 6A, B, and D). 

Phrase: "Therefore,"

Phrase: "the difference between nadir"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c at 3 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "significantly larger in SERCA3 +/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443228:larger [Quantitative Concept]
   770   C0549177:Larger [Quantitative Concept]
   770   C1704243:Larger [Quantitative Concept]

Phrase: "than SERCA3 -/- islets"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 in Fig. 6A,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0349966:Fig [Food]
   770   C0740116:+2 [Quantitative Concept]
   770   C1337208:FIG [Food]
   770   C1553638:6a [Medical Device]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.186: In contrast, when 20 mmol/l glucose induced a sustained elevation of [Ca2+]c, there was no difference between SERCA3 +/+ (233  8 nmol/l, n = 12) and SERCA3 -/- islets (225  13 nmol/l, n = 9); 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a sustained elevation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no difference between SERCA3 +/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "(233  8 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "(225  13 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.187: therefore, 3 with basal [Ca2+]c was similar (141  7 vs. 138  13 nmol/l). 

Phrase: "therefore,"

Phrase: "3 with basal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205112:Basal [Spatial Concept]
   790   C0439086:<3 [Quantitative Concept]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(141  7"

Phrase: "vs. 138  13 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.188: The differences between nadirs reflect differences in the amplitude of [Ca2+]c oscillations, which was smaller in SERCA3 +/+ than SERCA3 -/- islets (Fig. 6E). 

Phrase: "The differences between nadirs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differences in the amplitude of [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "]c oscillations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "was"

Phrase: "smaller in SERCA3 +/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "than SERCA3 -/- islets"

Phrase: "(Fig. 6E"

Phrase: ")."
Processing 00000000.tx.189: The frequency of [Ca2+]c oscillations was similar in the two types of islets during the last 5 min of perifusion with 7 mmol/l glucose but was much higher in SERCA3 +/+ than SERCA3 -/- islets in 10 mmol/l glucose (Fig. 6F). 

Phrase: "The frequency of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar in the two types of islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "during the last 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "of perifusion"

Phrase: "with 7 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "but"

Phrase: "was"

Phrase: "much higher in SERCA3 +/+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "than SERCA3 -/- islets"

Phrase: "in 10 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 6F"

Phrase: ")."
Processing 00000000.tx.190: The rate of the [Ca2+]c changes during the oscillations was also different. 

Phrase: "The rate of the [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "changes during the oscillations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]
   770   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "also different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.191: The increase and decrease in [Ca2+]c during the oscillations were clearly slower in SERCA3 +/+ than SERCA3 -/- islets (Fig. 7A and B). 

Phrase: "The increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "decrease in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c during the oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "clearly slower in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439834:Slow [Qualitative Concept]

Phrase: "than SERCA3 -/- islets"

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: View larger version (36K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 6. 

Phrase: "6."
Processing 00000000.tx.194: SERCA3 influences glucose-induced [Ca2+]c oscillations in mouse islets. 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "influences"

Phrase: "glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations in mouse islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillations [Therapeutic or Preventive Procedure]
Processing 00000000.tx.195: A and B: Isolated islets from SERCA3 +/+ or SERCA3 -/- mice were perifused with a medium containing 3, 7, 10, and 20 mmol/l glucose (G) as indicated. shows the difference between basal [Ca2+]c at 3 mmol/l glucose and the nadir of [Ca2+]c oscillations at 7 (1) or 10 mmol/l glucose (2) or the sustained [Ca2+]c elevation at 20 mmol/l glucose (3). 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Isolated islets from SERCA3 +/+"

Phrase: "or"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "perifused with a medium containing 3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "7,"

Phrase: "10,"

Phrase: "and"

Phrase: "20 mmol/l glucose (G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the difference between basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c at 3 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the nadir of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations at 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "10 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "the sustained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevation at 20 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.196: The traces are representative of results obtained in six (A) and five (B) islets. 

Phrase: "The traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "are"

Phrase: "representative of results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882932:Representative [Activity]

Phrase: "obtained in six"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205452:Six [Quantitative Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "(B) islets."
Processing 00000000.tx.197: C: Average [Ca2+]c calculated by integrating [Ca2+]c over the last 5 min of stimulation with each glucose concentration in all experiments similar to those illustrated in A and B. 

Phrase: "C"

Phrase: ":"

Phrase: "Average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "calculated by integrating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c over the last 5 min of stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1553033:[c] [Quantitative Concept]

Phrase: "with each glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427743:Glucose concentration [Laboratory Procedure]
  1000   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "illustrated in A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.198: D: Difference between basal [Ca2+]c at 3 mmol/l glucose and the nadir of [Ca2+]c oscillations at 7 (1) or 10 mmol/l glucose (2). 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Difference between basal"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1705241:*Difference [Quantitative Concept]
   790   C1705242:Difference [Qualitative Concept]
   718 E C0443199:Differential [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c at 3 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the nadir of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations at 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "or"

Phrase: "10 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.199: Amplitude (E) and frequency (F) of [Ca2+]c oscillations calculated during the last 5 min of perifusion with 7 or 10 mmol/l glucose. 

Phrase: "Amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "(E)"

Phrase: "and"

Phrase: "frequency (F) of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "calculated during the last 5 min of perifusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0444686:Calculated [Functional Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]

Phrase: "with 7"

Phrase: "or"

Phrase: "10 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.200: CF: Data are means  SE. 

Phrase: "CF"

Phrase: ":"

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.201: *P < 0.05, ** P < 0.01 for differences between SERCA3 +/+ and SERCA3 -/- islets.  

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "* P < 0.01 for differences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA3 -/- islets."
Processing 00000000.tx.202: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 7. 

Phrase: "7."
Processing 00000000.tx.204: SERCA3 influences glucose-induced [Ca2+]c oscillations in mouse islets and clusters of islet cells. 

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "influences"

Phrase: "glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "clusters of islet cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.205: Isolated islets (A and B) or clusters of islet cells (CE) from SERCA3 +/+ or SERCA3 -/- mice were perifused with a medium containing 10 (G10) or 20 mmol/l glucose (G20) as indicated. 

Phrase: "Isolated islets"

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "clusters of islet cells (CE)"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   819   C1179412:cells cluster [Body Part, Organ, or Organ Component]
   799 E C1522529:Islet Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "from SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "or"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "perifused with a medium containing 10"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "(G10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1538148:G10 [Gene or Genome]
  1000   C1823197:G10 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1540229:G20 [Gene or Genome]

Phrase: ")"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.206: Traces AD are representative of results obtained in six (A) and five (B) islets and in 8 (C) and 10 (D) clusters. 

Phrase: "Traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "AD"

Phrase: "are"

Phrase: "representative of results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882932:Representative [Activity]

Phrase: "obtained in six"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205452:Six [Quantitative Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "(B) islets"

Phrase: "and in 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "10"

Phrase: "("

Phrase: "D)"

Phrase: "clusters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.207: E: Average of 8 or 10 [Ca2+]c oscillations (1 oscillation taken per each experiment) induced by 20 mmol/l glucose in clusters of islets cells from SERCA3 +/+ and SERCA3 -/- mice, respectively. 

Phrase: "E"

Phrase: ":"

Phrase: "Average of 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1510992:Average [Quantitative Concept]
   790   C2825518:AVERAGE [Quantitative Concept]

Phrase: "or"

Phrase: "10"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "(1 oscillation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "taken per each experiment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: ")"

Phrase: "induced by 20 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "in clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "of islets cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   983   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA3 -/- mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "respectively."
Processing 00000000.tx.208: Simple averaging could be misleading because the oscillations have different durations. 

Phrase: "Simple averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1510992:Average [Quantitative Concept]
   827   C2825518:AVERAGE [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "misleading"

Phrase: "because"

Phrase: "the oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "different durations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449238:Durations [Temporal Concept]
   827 E C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.209: Averaging was thus performed at the onset and end of all oscillations to show the differences in mean rates of [Ca2+]c rise and decline in the two groups.  

Phrase: "Averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "was"

Phrase: "thus"

Phrase: "performed at the onset"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332162:Onset [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "end of all oscillations to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the differences in mean rates of [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "]c rise"

Phrase: "and"

Phrase: "decline in the two groups."
Processing 00000000.tx.210: Similar features were observed in clusters of islet cells in which glucose-induced [Ca2+]c oscillations are slower and often more regular than in islets (Fig. 7C and D). 

Phrase: "Similar features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "observed in clusters of islet cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   767   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   756 E C1522529:Islet Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C1441672:Observed [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1555715:Cluster [Idea or Concept]
   719   C1704332:Cluster [Quantitative Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in which glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "slower"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "and"

Phrase: "often more regular than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205272:Regular [Qualitative Concept]

Phrase: "in islets"

Phrase: "(Fig. 7C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.211: Average [Ca2+]c integrated over 15 min of perifusion with 20 mmol/l glucose was similar in SERCA3 +/+ (287  28 nmol/l, n = 8) and in SERCA3 -/- cells (286  24 nmol/l, n = 10). 

Phrase: "Average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "integrated over 15 min of perifusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "with 20 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "similar in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "(287  28 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and in SERCA3 -/- cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1412639:SERCA3 [Gene or Genome]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(286  24 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.212: The nadir between [Ca2+]c oscillations was higher (P < 0.01) in SERCA3 +/+ than SERCA3 -/- cells (60  8 vs. 35  4 nmol/l above basal [Ca2+]c in a Ca2+-free medium, respectively, not shown in Fig. 7C and D). 

Phrase: "The nadir between"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1708760:Nadir [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "than SERCA3 -/- cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(60  8"

Phrase: "vs. 35  4 nmol/l above basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   778   C0439282:nmol/L [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "a Ca2+-free medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "respectively,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown in Fig. 7C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.213: The amplitude of [Ca2+]c oscillations was smaller in SERCA3 +/+ than SERCA3 -/- clusters of cells (306  33 vs. 424  41 nmol/l, P < 0.05). 

Phrase: "The amplitude of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "smaller in SERCA3 +/+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "than SERCA3 -/- clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555715:Cluster [Idea or Concept]
   827   C1704332:Cluster [Quantitative Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(306  33"

Phrase: "vs. 424  41 nmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439282:nmol/L [Quantitative Concept]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.214: In addition, differences in the rate of [Ca2+]c changes during the oscillations can be seen in the representative experiments shown in Fig. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "differences in the rate of [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "changes during the oscillations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]
   770   C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "seen in the representative experiments"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205397:Seen [Qualitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1882932:Representative [Activity]
   726 E C0042789:see [Organism Function]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947903:See [Activity]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.215: 7C and D and become even more evident when single oscillations from all experiments are pooled (Fig. 7E). 

Phrase: "7C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "become"

Phrase: "even more evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0332120:Evidence [Functional Concept]

Phrase: "when"

Phrase: "single oscillations from all experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "(Fig. 7E"

Phrase: ")."
Processing 00000000.tx.216: At the onset of the oscillation, the [Ca2+]c rise is faster and larger in SERCA3 -/- than SERCA3 +/+ clusters. 

Phrase: "At the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of the oscillation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise"

Phrase: "is"

Phrase: "faster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "larger in SERCA3 -/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "than SERCA3 +/+ clusters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555715:Cluster [Idea or Concept]
   827   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.217: At the end of the oscillation, the return to basal [Ca2+]c is also faster with no slow component. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the oscillation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "the return to basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332156:Return to [Qualitative Concept]
           Return

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "also faster with no slow component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0015663:Fast [Finding]
   719   C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.218: These characteristics of the glucose-induced [Ca2+]c oscillations are similar to those of the [Ca2+]c changes induced by pulses of high K+ (Fig. 5), which highlights the important contribution of SERCA3 in [Ca2+]c oscillations resulting from periodic Ca2+ influx. 

Phrase: "These characteristics of the glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "similar to those of the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "]c changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "induced by pulses of high K+ (Fig. 5"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   767   C0444989:K 5 [Intellectual Product]
   744   C0034107:Pulses [Health Care Activity]
   744   C0205250:High [Qualitative Concept]
   744   C0205263:Induced [Functional Concept]
   744   C0349966:Fig [Food]
   744   C0391850:PULSES [Physiologic Function]
   744   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1299351:High [Qualitative Concept]
   744   C1337208:FIG [Food]
   744   C1708601:K' [Quantitative Concept]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0232117:PULSE [Clinical Attribute]
   711 E C1947910:Pulse [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "highlights"

Phrase: "the important contribution of SERCA3 in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "resulting from periodic Ca2+ influx."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0332182:Periodic [Temporal Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0678226:resulting [Functional Concept]
   760   C1706381:PERIODIC [Intellectual Product]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.219: SERCA3 ablation does not impair glucose tolerance and glucose-induced insulin secretion. 

Phrase: "SERCA3 ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "glucose-induced insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.220: Blood glucose concentrations were similar in fed SERCA3 +/+ (120  3 mg/dl, n = 17) and SERCA3 -/- mice (111  4 mg/dl, n = 17). 

Phrase: "Blood glucose concentrations"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C2585282:Blood glucose concentration [Finding]
   913   C0427728:blood concentrations [Laboratory or Test Result]
   913   C0699870:blood concentrations [Quantitative Concept]
   913   C1313904:blood concentrations [Laboratory Procedure]
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "were"

Phrase: "similar in fed SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(120  3 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "n = 17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(111  4 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "n = 17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.221: There was also no difference after 24 h fasting (90  10 mg/dl, n = 14 and 89  9 mg/dl, n = 14, two samplings in each mouse). 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "no difference after 24 h fasting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "(90  10 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "n = 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "89  9 mg/dl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439269:mg dl [Quantitative Concept]
   812   C3642216:/dL [Quantitative Concept]

Phrase: "n = 14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "two samplings in each mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0441621:Sampling [Diagnostic Procedure]
   726   C0870078:Sampling [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.222: The increase in blood glucose occurring after refeeding was not different between the two groups (Fig. 8A), suggesting that SERCA3 ablation does not impair glucose homeostasis. 

Phrase: "The increase in blood glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "occurring after refeeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "was"

Phrase: "not different between the two groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that SERCA3 ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.223: Plasma insulin was also similar in SERCA3 +/+ (2.2  0.5 ng/ml, n = 11) and SERCA3 -/- fed mice (2.0  0.4 ng/ml, n = 11). 

Phrase: "Plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "also similar in SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "(2.2  0.5 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- fed mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(2.0  0.4 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439275:ng/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: "n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.224: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.225: 8. 

Phrase: "8."
Processing 00000000.tx.226: SERCA3 ablation does not impair glucose tolerance and glucose-induced insulin secretion. 

Phrase: "SERCA3 ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "glucose-induced insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.227: A: SERCA3 +/+ ( and ) and SERCA3 -/- mice ( and ) were fasted for 24 h. 

Phrase: "A"

Phrase: ":"

Phrase: "SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "("

Phrase: "and )"

Phrase: "and"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "("

Phrase: "and )"

Phrase: "were"

Phrase: "fasted for 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.228: After a first measurement of blood glucose (time zero), the animals were refed ad libitum ( and ) and blood glucose was again measured 1 and 3 h later. 

Phrase: "After a first measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]

Phrase: "of blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(time zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0919414:Zero [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "refed"

Phrase: "ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "("

Phrase: "and )"

Phrase: "and"

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "again"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "3 h later."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0041119:3 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.229: One week later, the same animals ( and ) were fasted again, and blood glucose was measured after 24 (time zero), 25, and 27 h of fasting. 

Phrase: "One week later,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332174:/week [Temporal Concept]
   827   C0439230:week [Temporal Concept]

Phrase: "the same animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "("

Phrase: "and )"

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "again,"

Phrase: "and"

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "measured after 24"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(time zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0919414:Zero [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "25,"

Phrase: "and"

Phrase: "27 h of fasting."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.230: Results are expressed as differences () from blood glucose at time zero (arrow) for each animal (90  10 mg/dl in SERCA3 +/+ and 89  9 mg/dl in SERCA3 -/- mice). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "from blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "at time zero"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0919414:Zero [Quantitative Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "for each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "(90  10 mg/dl in SERCA3 +/+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439269:mg dl [Quantitative Concept]
   783 E C3463848:dl mg [Quantitative Concept]
   753   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "89  9 mg/dl in SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0439269:mg dl [Quantitative Concept]
   774 E C3463848:dl mg [Quantitative Concept]
   748   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.231: Values are means  SE of results obtained with seven mice for each group. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of results"

Phrase: "obtained with seven mice"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0205453:Seven [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "for each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.232: B: Batches of 15 islets from SERCA3 +/+ () and SERCA3 -/- mice () were perifused with a medium containing 3, 8, 12, or 15 mmol/l glucose (G) or 100 mol/l tolbutamide (Tolb), as indicated. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Batches of 15 islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1550176:Batch [Idea or Concept]
   770   C1948031:Batch [Quantitative Concept]

Phrase: "from SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "("

Phrase: ")"

Phrase: "were"

Phrase: "perifused with a medium containing 3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009458:Medium [Intellectual Product]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "8,"

Phrase: "12,"

Phrase: "or"

Phrase: "15 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "100 mol/l tolbutamide (Tolb),"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   756 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.233: Insulin secretion is expressed as a percentage of islet insulin content. 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "expressed as a percentage of islet insulin content."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0423896:Content [Mental Process]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0456205:Content [Conceptual Entity]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.234: Values are means  SE of seven experiments.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE of seven experiments."
Processing 00000000.tx.235: Glucose-induced insulin secretion was evaluated in vitro with perifused islets. 

Phrase: "Glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "in vitro with perifused islets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.236: Stimulation with 15 mmol/l glucose, after 40 min of perifusion with 3 mmol/l glucose, induced biphasic insulin release that was larger in SERCA3 -/- than SERCA3 +/+ islets (Fig. 8B). 

Phrase: "Stimulation with 15 mmol/l glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "after"

Phrase: "40 min of perifusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with 3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "biphasic insulin release"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0356369:Biphasic Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "was"

Phrase: "larger in SERCA3 -/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "than SERCA3 +/+ islets"

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.237: Thus, the percentage of insulin secreted over the 30 min of stimulation relative to the islet insulin content was 1.8  0.3 vs. 

Phrase: "Thus,"

Phrase: "the percentage of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "secreted over the 30 min of stimulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1327616:Secreted [Cell Function]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "relative to the islet insulin content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "1.8  0.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "vs."
Processing 00000000.tx.238: 1.0  0.2%, P < 0.05. 

Phrase: "1.0  0.2%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0580272:1/2 [Intellectual Product]
   902   C1519043:1-2 [Research Activity]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.239: After a 20-min period rest at 3 mmol/l glucose, the islets were stimulated by stepwise increases of the glucose concentration to 8 and 12 mmol/l and, eventually, by 100 mol/l tolbutamide (Fig. 8B). 

Phrase: "After a 20-min period rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035253:Rest [Daily or Recreational Activity]
   812   C1622890:ResT [Molecular Function]

Phrase: "at 3 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "the islets"

Phrase: "were"

Phrase: "stimulated by stepwise increases of the glucose concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0427743:Glucose concentration [Laboratory Procedure]
   770   C1287281:Glucose concentration [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0086045:Concentration [Mental Process]
   744   C0442805:increases [Functional Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "to 8"

Phrase: "and"

Phrase: "12 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "eventually,"

Phrase: "by 100 mol/l tolbutamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   756 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.240: During these three periods of stimulation, fractional insulin secretion was not different between SERCA3 +/+ and SERCA3 -/- islets.  

Phrase: "During these three periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "fractional insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "not different between SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "SERCA3 -/- islets."
Processing 00000000.tx.241: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The present study shows that in the mouse pancreas, SERCA3 is present only in insulin-secreting -cells. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in the mouse pancreas,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1518865:Mouse Pancreas [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   760   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "only in insulin-secreting -cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   862   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205171:Only [Quantitative Concept]
   760   C1327616:Secreting [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1720467:Only [Intellectual Product]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.242: By using the recently generated SERCA3 knockout mice (29), we also demonstrate that SERCA3 does not contribute to glucose-induced Ca2+ uptake by the ER at basal [Ca2+]c but has a specific role in the modulation of [Ca2+]c oscillations induced by periodic Ca2+ influx in -cells. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the recently generated SERCA3 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "we also"

Phrase: "demonstrate"

Phrase: "that SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contribute to glucose-induced Ca2+ uptake"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1159527:glucose uptake [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1880177:Contribute [Activity]

Phrase: "by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "but"

Phrase: "has"

Phrase: "a specific role in the modulation of [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by periodic Ca2+ influx in -cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0205263:Induced [Functional Concept]
   748   C0332182:Periodic [Temporal Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1706381:PERIODIC [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.243: Finally, SERCA3 expression is dispensable for normal insulin secretion and glucose homeostasis in mice maintained under normal conditions. 

Phrase: "Finally,"

Phrase: "SERCA3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "dispensable for normal insulin secretion"

Phrase: "and"

Phrase: "glucose homeostasis in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1326961:glucose homeostasis [Physiologic Function]
   770   C0019868:Homeostasis [Biologic Function]

Phrase: "maintained under normal conditions."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   816   C0231162:Normal condition [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0024501:Maintain [Activity]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.244: The model. 

Phrase: "The model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.245: Pancreatic islets express SERCA2b and the three SERCA3 isoforms (SERCA3ac) (1,39). 

Phrase: "Pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "express"

Phrase: "SERCA2b"

Phrase: "and"

Phrase: "the three SERCA3 isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(SERCA3ac"

Phrase: ")"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.246: The SERCA3 -/- mouse model permits investigation of the role of all SERCA3 isoforms together, but not that of individual isoforms, because excision of part of exon 5 during processing of the primary transcript blocks the pump activity of all three alternatively spliced isoforms, which are the product of the same gene but differ by no, partial, or total retention of exon 21 (1). 

Phrase: "The SERCA3 -/- mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "investigation of the role of all SERCA3 isoforms together,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1261322:Investigation [Health Care Activity]
   742   C1552578:investigation [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that of individual isoforms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   770   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "because"

Phrase: "excision of part of exon 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:excision [Therapeutic or Preventive Procedure]
   753   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "during processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "of the primary transcript"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the pump activity of all three alternatively spliced isoforms,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1153663:pump activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "are"

Phrase: "the product of the same gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "but"

Phrase: "differ by no,"

Phrase: "partial,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728938:Partial [Quantitative Concept]
  1000   C1550516:partial [Idea or Concept]

Phrase: "or"

Phrase: "total retention of exon 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035280:Retention [Mental Process]
   760   C0333117:Retention [Functional Concept]
   760   C1753315:retention [Cell Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.247: RT-PCR did no reveal any obvious difference in the expression level of SERCA2 mRNA (presumably SERCA2b) between SERCA3 +/+ and SERCA3 -/- islets, suggesting that the loss of SERCA3 activity is not compensated for by an overexpression of SERCA2 in islets of SERCA3-deficient mice. 

Phrase: "RT-PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "did"

Phrase: "no"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any obvious difference in the expression level of SERCA2 mRNA (presumably SERCA2b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: ")"

Phrase: "between SERCA3 +/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA3 -/- islets,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the loss of SERCA3 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "compensated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205432:Compensated [Qualitative Concept]

Phrase: "by an overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of SERCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916183:serca2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412638:SERCA2 [Gene or Genome]

Phrase: "in islets"

Phrase: "of SERCA3-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.248: Immunolocalization of SERCA3 and islet hormones showed that within the islet, SERCA3 expression is restricted to -cells. 

Phrase: "Immunolocalization of SERCA3"

Phrase: "and"

Phrase: "islet hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that within the islet,"

Phrase: "SERCA3 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: "to -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.249: This makes the interpretation of [Ca2+]c measurements easier because any difference in [Ca2+]c changes between SERCA3 +/+ and SERCA3 -/- islets can be attributed specifically to -cells. 

Phrase: "This"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the interpretation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "easier"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0332219:Easy [Qualitative Concept]
   916 E C1331418:Ease [Mental Process]

Phrase: "because"

Phrase: "any difference in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "changes between SERCA3 +/+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1412639:SERCA3 [Gene or Genome]
   790   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "can"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "specifically to -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.250: The lack of SERCA3 immunoreactivity in pancreatic acini has been documented previously (12). 

Phrase: "The lack of SERCA3 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in pancreatic acini"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0227578:pancreatic acini [Body Part, Organ, or Organ Component]
   983 E C1280423:Pancreatic acinus [Body Part, Organ, or Organ Component]
   827   C0935597:Acinus [Body Part, Organ, or Organ Component]
   827   C1442495:ACINUS [Gene or Genome]
   777 E C0332207:Acinar [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.251: Role of SERCA3 when [Ca2+]c is low in -cells. 

Phrase: "Role of SERCA3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "when"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "low in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.252: Voltage-dependent Ca2+ channels are the main Ca2+ entry pathway in the electrically excitable -cell (40). 

Phrase: "Voltage-dependent Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "the main Ca2+ entry pathway in the electrically excitable -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.253: A small capacitative Ca2+ entry (through voltage-independent Ca2+ channels) can also be evoked when TG, a SERCA inhibitor, or IP3-producing agents deplete the Ca2+ content of the ER (41,42). 

Phrase: "A small capacitative Ca2+ entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705654:Entry [Intellectual Product]

Phrase: "("

Phrase: "through voltage-independent Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "when"

Phrase: "TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "a SERCA inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1999216:Inhibitor [Qualitative Concept]
   771   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "IP3-producing agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "the Ca2+ content of the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.254: However, because this entry mechanism inactivates rapidly in a Ca2+-dependent manner (43), it is best detected upon readdition of Ca2+ to a Ca2+-free medium. 

Phrase: "However,"

Phrase: "because"

Phrase: "this entry mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "inactivates"

Phrase: "rapidly in a Ca2+-dependent manner"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1637379:Rapidly [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "detected upon readdition of Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "to a Ca2+-free medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
Processing 00000000.tx.255: Moreover, Ca2+ influx through this pathway is small and barely increases [Ca2+]c in the steady state (42). 

Phrase: "Moreover,"

Phrase: "Ca2+ influx through this pathway"

Phrase: "is"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "and"

Phrase: "barely increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the steady state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678587:steady state [Natural Phenomenon or Process]
   861   C0205361:Steady [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.256: This probably explains why no significant differences in basal [Ca2+]c levels were observed here between islets that were or were not pretreated with TG. 

Phrase: "This probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "explains"

Phrase: "why"

Phrase: "no significant differences in basal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "here between islets"

Phrase: "that"

Phrase: "were"

Phrase: "or"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "pretreated with TG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.257: This lack of difference also indicates that basal [Ca2+]c in -cells is mainly set by Ca2+ extrusion systems other than the SERCAs. 

Phrase: "This lack of difference also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "indicates"

Phrase: "that basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C0229579:C-Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "set by Ca2+ extrusion systems"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0036849:Set [Mental Process]
   760   C0443213:Extrusion [Finding]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "other than the SERCAs."
Processing 00000000.tx.258: Stimulation of -cells with glucose induces an initial TG-inhibitable drop in [Ca2+]c that precedes the [Ca2+]c rise and is explained by Ca2+ being pumped into the ER (18,42). 

Phrase: "Stimulation of -cells with glucose"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an initial TG-inhibitable drop in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "that"

Phrase: "precedes"

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c rise"

Phrase: "and"

Phrase: "is"

Phrase: "explained by Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "being"

Phrase: "pumped into the ER"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0182537:pumped [Medical Device]
   726 E C1706421:Pump [Manufactured Object]

Phrase: "(18,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.259: As this drop was of similar amplitude in SERCA3 -/- and SERCA3 +/+ mice, we can rule out the intervention of SERCA3 in this phenomenon. 

Phrase: "As this drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]

Phrase: "was of similar amplitude"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C2346753:Amplitude [Spatial Concept]
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "and"

Phrase: "SERCA3 +/+ mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "we"

Phrase: "can"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the intervention of SERCA3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0886296:intervention [Health Care Activity]
   770   C1273869:Intervention [Health Care Activity]
   770   C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "in this phenomenon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]
Processing 00000000.tx.260: Likewise, SERCA3 does not seem to be involved in the glucose-induced replenishment of the IP3-sensitive and -insensitive Ca2+ pools of the ER, nor in the maintenance of their Ca2+ content at basal [Ca2+]c over time. 

Phrase: "Likewise,"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the glucose-induced replenishment of the IP3-sensitive"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
   739   C0205263:Induced [Functional Concept]
   739   C0332324:Sensitive [Functional Concept]
   739   C1314939:Involved [Functional Concept]
   739   C1550474:sensitive [Idea or Concept]
   739   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "and -"

Phrase: "insensitive Ca2+ pools of the ER,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0337051:pools [Geographic Area]
   714 E C1509144:pool [Clinical Attribute]
   714 E C2349200:Pool [Functional Concept]

Phrase: "nor in the maintenance of their Ca2+ content"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0024501:Maintenance [Activity]
   744   C0028423:NOR [Geographic Area]
   744   C0028609:NOR [Cell Component]
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1513854:NOR [Mammal]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c over time."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0719058:C-Time [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.261: Indeed, ACh and TG elicited similar Ca2+ mobilizations in SERCA3 +/+ and SERCA3 -/- -cells preexposed to glucose. 

Phrase: "Indeed,"

Phrase: "ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "similar Ca2+ mobilizations in SERCA3 +/+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0185112:mobilizations [Therapeutic or Preventive Procedure]
   726 E C0300926:mobilization [Functional Concept]

Phrase: "and"

Phrase: "SERCA3 -/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "- -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "preexposed to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.262: Glucose-induced Ca2+ uptake by the ER at basal [Ca2+]c is thus probably mediated by SERCA2b, the other SERCA isoform expressed in -cells, which is compatible with its much higher affinity for Ca2+ (K1/2 of 0.2 mol/l) relative to that of SERCA3 (K1/2 of 2 mol/l) (1,10,11,44). 

Phrase: "Glucose-induced Ca2+ uptake by the ER"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1159527:glucose uptake [Cell Function]
   744   C0243144:Uptake [Physiologic Function]
   744   C0347980:% uptake [Quantitative Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "thus probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750492:Probably [Idea or Concept]

Phrase: "mediated by SERCA2b,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "the"

Phrase: "other SERCA isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   771   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "expressed"

Phrase: "in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "is"

Phrase: "compatible with its much higher affinity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332290:compatible [Idea or Concept]
   753   C1524057:Compatible [Qualitative Concept]

Phrase: "for Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(K1/2 of 0.2 mol/l) relative"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0347982:mol/L [Quantitative Concept]
   744   C0027960:Mole [Neoplastic Process]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0324740:Mole [Mammal]
   744   C0439189:Mole [Quantitative Concept]
   744   C1456781:mole [Neoplastic Process]
   744   C1547039:*Relative [Quantitative Concept]
   744   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1824986:mol [Gene or Genome]
   744   C3272787:K1 [Gene or Genome]

Phrase: "to that"

Phrase: "of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(K1/2 of 2 mol/l) (1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0347982:mol/L [Quantitative Concept]
   748   C0027960:Mole [Neoplastic Process]
   748   C0324740:Mole [Mammal]
   748   C0439189:Mole [Quantitative Concept]
   748   C1456781:mole [Neoplastic Process]
   748   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1824986:mol [Gene or Genome]
   748   C3272787:K1 [Gene or Genome]

Phrase: "10,"

Phrase: "11,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.263: A recent study suggested that decreased expression of SERCA2, but not SERCA3, by injection of specific antisense oligonucleotides reduced the Ca2+ content of the ER at basal [Ca2+]c (13). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that decreased expression of SERCA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not SERCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412639:SERCA3 [Gene or Genome]

Phrase: "by injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of specific antisense oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0079925:Anti-Sense Oligonucleotides [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the Ca2+ content of the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c (13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.264: Role of SERCA3 in [Ca2+]c oscillations induced by periodic Ca2+ influx in -cells. 

Phrase: "Role of SERCA3 in [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by periodic Ca2+ influx in -cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0205263:Induced [Functional Concept]
   748   C0332182:Periodic [Temporal Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1706381:PERIODIC [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.265: We previously demonstrated that the ER shapes [Ca2+]c oscillations induced by periodic Ca2+ influx in -cells (21). 

Phrase: "We previously"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the ER shapes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0332479:Shapes [Spatial Concept]
   793 E C0348078:shape [Qualitative Concept]
   793 E C0522512:Shape [Spatial Concept]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by periodic Ca2+ influx in -cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0205263:Induced [Functional Concept]
   748   C0332182:Periodic [Temporal Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1706381:PERIODIC [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.266: It limits the amplitude of the oscillation by rapidly taking up Ca2+ during the upstroke and prolongs the duration of the oscillation by slowly releasing Ca2+ into the cytosol after Ca2+ influx has stopped. 

Phrase: "It"

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the amplitude of the oscillation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "by rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "taking up Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   756   C1515187:Take [Health Care Activity]

Phrase: "during the upstroke"

Phrase: "and"

Phrase: "prolongs"

Phrase: "the duration of the oscillation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "by slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "into the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "after Ca2+ influx"

Phrase: "has"

Phrase: "stopped."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272691:stopped [Qualitative Concept]
   966 E C1947925:Stop [Activity]
   966 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.267: These findings are confirmed here by the observation that high K+-induced transient [Ca2+]c elevations were larger and devoid of a slow recovery phase in islets whose SERCAs were blocked by TG. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "here by the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that high K+-induced transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040704:Transient [Population Group]
   812   C0205374:Transient [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0702240:elevations [Spatial Concept]
   827 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "devoid of a slow recovery phase in islets"

Phrase: "whose SERCAs"

Phrase: "were"

Phrase: "blocked by TG."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0028778:Blocked [Pathologic Function]
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.268: Importantly, our present results also demonstrate that this effect of the ER can largely be attributed to the activity of SERCA3. 

Phrase: "Importantly,"

Phrase: "our present results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "this effect of the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "largely"

Phrase: "be"

Phrase: "attributed to the activity of SERCA3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C1879549:Activity Attribute [Qualitative Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1412639:SERCA3 [Gene or Genome]
   753   C1561536:*Activity [Idea or Concept]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.269: Thus, high K+-induced transient [Ca2+]c elevations in SERCA3 -/- islets were similar to those in SERCA3 +/+ islets pretreated with TG and were virtually unaffected by TG pretreatment. 

Phrase: "Thus,"

Phrase: "high K+-induced transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040704:Transient [Population Group]
   812   C0205374:Transient [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations in SERCA3 -/- islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0702240:elevations [Spatial Concept]
   726 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "similar to those in SERCA3 +/+ islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "pretreated with TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "were"

Phrase: "virtually unaffected by TG pretreatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.270: The present results further show that SERCA3 also plays a role during [Ca2+]c oscillations induced by glucose. 

Phrase: "The present results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that SERCA3 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412639:SERCA3 [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.271: The amplitude of these oscillations was indeed larger and their nadir lower in SERCA3 -/- than SERCA3 +/+ islets. 

Phrase: "The amplitude of these oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "indeed larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "their nadir"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708760:Nadir [Qualitative Concept]

Phrase: "lower in SERCA3 -/-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "than SERCA3 +/+ islets."
Processing 00000000.tx.272: As for high K+-induced transient [Ca2+]c elevations, the larger amplitude of glucose-induced [Ca2+]c oscillations likely results from reduced Ca2+ uptake by the ER in SERCA3 -/- -cells. 

Phrase: "As for high K+-induced transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040704:Transient [Population Group]
   812   C0205374:Transient [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c elevations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0702240:elevations [Spatial Concept]
   827 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "the larger amplitude of glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "results from reduced Ca2+ uptake"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "in SERCA3 -/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "- -"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.273: As a consequence, less or no Ca2+ is slowly released by the ER during the intervals, and the return of [Ca2+]c to basal levels is not impeded (the nadir is lower) before the next [Ca2+]c oscillation starts. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "or"

Phrase: "no Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "released by the ER"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during the intervals,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272706:intervals [Temporal Concept]
   966 E C1552654:Interval [Idea or Concept]
   966 E C1552713:Interval [Intellectual Product]

Phrase: "and"

Phrase: "the return of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c to basal levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impeded"

Phrase: "("

Phrase: "the nadir"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708760:Nadir [Qualitative Concept]

Phrase: "is"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: ")"

Phrase: "before the next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillation starts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0439659:Start [Temporal Concept]
Processing 00000000.tx.274: Blockade of all SERCAs by TG is known to augment glucose-induced [Ca2+]c increase by activating a depolarizing store-operated current, which then facilitates the opening of voltage-dependent Ca2+ channels (18,42,45,46). 

Phrase: "Blockade of all SERCAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332206:Blockade [Functional Concept]
   770   C3540676:Blockade [Pharmacologic Substance]

Phrase: "by TG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c increase by activating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "a depolarizing store-operated current,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0521116:Current [Temporal Concept]
   812   C1705970:Current [Natural Phenomenon or Process]

Phrase: "which then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "facilitates"

Phrase: "the opening of voltage-dependent Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0175566:Opening [Spatial Concept]
   748   C1882151:Opening [Spatial Concept]

Phrase: "(18,"

Phrase: "42,"

Phrase: "45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.275: However, selective loss of SERCA3 did not increase average [Ca2+]c compared with control islets, probably because the activity of SERCA2 prevented activation of a store-operated current with a similar amplitude to that induced by TG. 

Phrase: "However,"

Phrase: "selective loss of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "compared with control islets,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "because"

Phrase: "the activity of SERCA2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "activation of a store-operated current"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "with a similar amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "to that"

Phrase: "induced by TG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.276: A distinct subcellular distribution of various SERCA isoforms has been reported in acinar cells (12) but not in Jurkat T or HEK-293 cells expressing SERCA2b and SERCA3 (44). 

Phrase: "A distinct subcellular distribution of various SERCA isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0520511:distribution [Idea or Concept]
   738   C1704711:Distribution [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in acinar cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0596030:Acinar Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0332207:Acinar [Spatial Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3282337:Cells [Cell]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(12"

Phrase: ")"

Phrase: "but"

Phrase: "not in Jurkat T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "SERCA2b"

Phrase: "and"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.277: Spatial separation of SERCAs with distinct Ca2+ affinities might explain the existence of subcompartments of the ER with high and low Ca2+ concentrations (47). 

Phrase: "Spatial separation of SERCAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036679:Separation [Pathologic Function]
   770   C0237868:Separation [Social Behavior]
   770   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "with distinct Ca2+ affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "might"

Phrase: "explain"

Phrase: "the existence of subcompartments of the ER"

Phrase: "with high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "low Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.278: Whether the high Ca2+-affinity SERCA2b, operating mainly at low [Ca2+]c, and the low Ca2+-affinity SERCA3, operating when [Ca2+]c increases are localized at distinct sites of the ER best fitting their specific roles, remains to be investigated in -cells. 

Phrase: "Whether"

Phrase: "the high Ca2+-affinity SERCA2b,"

Phrase: "operating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3242339:operate [Functional Concept]

Phrase: "mainly at low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205251:low [Qualitative Concept]
   790   C1299352:Low [Qualitative Concept]
   790   C1550472:low [Idea or Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the low Ca2+-affinity SERCA3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412639:SERCA3 [Gene or Genome]

Phrase: "operating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3242339:operate [Functional Concept]

Phrase: "when"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "are"

Phrase: "localized at distinct sites of the ER"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   754   C2945843:Site of [Qualitative Concept]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C0205145:Sites [Spatial Concept]
   744   C0392752:Localized [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "best"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]

Phrase: "fitting"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0036572:Fitting [Sign or Symptom]
  1000   C0441548:Fitting [Health Care Activity]
   966 E C0424576:Fit [Finding]
   966 E C2349186:Fit [Activity]

Phrase: "their specific roles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.279: SERCA3 ablation does not impair glucose tolerance and insulin secretion in mice. 

Phrase: "SERCA3 ablation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547070:Ablation [Therapeutic or Preventive Procedure]
   861   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion in mice."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.280: Glucose-induced [Ca2+]c responses are altered in islets from animal models of type 2 diabetes (22,23), and several studies have incriminated a reduced activity of Ca2+-ATPase (24), all SERCAs (25), or more specifically SERCA3 (5,26,27). 

Phrase: "Glucose-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "altered in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392747:Altered [Functional Concept]

Phrase: "from animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "incriminated"

Phrase: "a reduced activity of Ca2+-ATPase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0086439:Reduced Activity [Sign or Symptom]
   783   C1148926:ATPase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "all SERCAs"

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "more specifically SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412639:SERCA3 [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.281: The present experiments with SERCA3 -/- mice do not support this suggestion. 

Phrase: "The present experiments with SERCA3 -/- mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this suggestion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038659:Suggestion [Idea or Concept]
  1000   C1705535:suggestion [Idea or Concept]
Processing 00000000.tx.282: Indeed, SERCA3 -/- mice were normoglycemic, had a normal insulinemia and body weight, and showed essentially the same response to a refeeding test as SERCA3 +/+ mice. 

Phrase: "Indeed,"

Phrase: "SERCA3 -/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "normoglycemic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580545:Normoglycaemic [Finding]

Phrase: "had"

Phrase: "a normal insulinemia"

Phrase: "and"

Phrase: "body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "essentially"

Phrase: "the same response to a refeeding test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "as SERCA3 +/+ mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.283: Moreover, perifused islets from SERCA3 -/- mice displayed a similar or better insulin secretory response to glucose than did islets from their wild-type littermates. 

Phrase: "Moreover,"

Phrase: "perifused islets from SERCA3 -/- mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C1522528:Mouse Islets [Tissue]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "better insulin secretory response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "than"

Phrase: "did"

Phrase: "islets from their wild-type littermates."
Processing 00000000.tx.284: The reasons for this are unclear because average [Ca2+]c was similar between the two types of islets. 

Phrase: "The reasons for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392360:reasons [Idea or Concept]

Phrase: "are"

Phrase: "unclear"

Phrase: "because"

Phrase: "average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "was"

Phrase: "similar between the two types of islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.285: Differences in the kinetics of [Ca2+]c changes during the oscillations might allow [Ca2+]c to stay above the threshold for exocytosis for longer periods of time in SERCA3 -/- than SERCA3 +/+ -cells. 

Phrase: "Differences in the kinetics of [Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "changes during the oscillations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]
   770   C1705241:Change [Quantitative Concept]

Phrase: "might"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "stay above the threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "for exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "for longer periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "in SERCA3 -/-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "than SERCA3 +/+ -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.286: Localized [Ca2+]c in zones of exocytosis might also be higher after ablation of the buffering effect of SERCA3. 

Phrase: "Localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c in zones of exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2265763:C zone [Cell Component]
   726   C1710706:Zone [Spatial Concept]

Phrase: "might"

Phrase: "also"

Phrase: "be"

Phrase: "higher after ablation of the buffering effect of SERCA3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.287: The essentially normal glucose tolerance and insulin secretion of SERCA3 -/- mice suggest that the mutations or polymorphisms of the SERCA3 gene reported in type 2 diabetic patients (27) are not causally involved in the development of diabetes. 

Phrase: "The essentially normal glucose tolerance"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   861   C0178665:Glucose tolerance [Physiologic Function]
   861   C0860800:normal glucose [Finding]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0205307:Normal [Qualitative Concept]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0439166:% normal [Quantitative Concept]
   812   C1704410:Tolerance [Qualitative Concept]
   812   C2347086:% Normal [Quantitative Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion of SERCA3 -/- mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "polymorphisms of the SERCA3 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0678951:gene polymorphisms [Genetic Function]
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "reported in type 2 diabetic patients"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0441730:Type 2 [Classification]
   767   C0585733:Report type [Intellectual Product]
   767   C0747307:patients report [Intellectual Product]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1547052:*Type [Quantitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "(27"

Phrase: ")"

Phrase: "are"

Phrase: "not causally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "involved in the development of diabetes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1314939:Involved [Functional Concept]
   753   C1527148:Development [Functional Concept]
Processing 00000000.tx.288: The reduced expression or activity of SERCA3 observed in type 2 diabetes could result partly from the associated hyperglycemia. 

Phrase: "The reduced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "activity of SERCA3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "observed in type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "could"

Phrase: "result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "partly from the associated hyperglycemia."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]
   760   C0332281:Associated [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.289: Indeed, culturing rat islets in high glucose concentrations decreased their Ca2+-ATPase activity (24). 

Phrase: "Indeed,"

Phrase: "culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "rat islets in high glucose concentrations"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "their Ca2+-ATPase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1148926:ATPase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.290: Moreover, the large reduction of SERCA3 expression that was observed in rats rendered hyperglycemic by 90% pancreatectomy was completely reversed after normalization of the glycemia by phlorizin treatment (26). 

Phrase: "Moreover,"

Phrase: "the large reduction of SERCA3 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "observed in rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "rendered"

Phrase: "hyperglycemic by 90% pancreatectomy"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "reversed after normalization of the glycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005802:glycemia [Carbohydrate]
   753   C1882115:Normalization [Research Activity]
   719   C1555029:Reverse [Idea or Concept]

Phrase: "by phlorizin treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.291: Another possibility is that SERCA3 knockout mice have developed compensatory mechanisms that type 2 diabetic patients have not. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that SERCA3 knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206745:Knock-out Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "developed compensatory mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "that type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.292: Indeed, a recent study using mice lacking one copy of the SERCA2 gene indicated that Ca2+ signaling mechanisms exhibit a high degree of plasticity (48). 

Phrase: "Indeed,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "one copy of the SERCA2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948062:Copy [Manufactured Object]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that Ca2+ signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high degree of plasticity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.293: Further studies will be needed to determine whether alteration in SERCA3 activity could increase susceptibility to diabetes development in a predisposing environment. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "alteration in SERCA3 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0184517:Activity alteration [Finding]
   770   C1515926:Alteration [Idea or Concept]

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "susceptibility to diabetes development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "in a predisposing environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.294: Our data demonstrate that within the pancreas, SERCA3 is expressed in -cells only. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that within the pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   770   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "is"

Phrase: "expressed"

Phrase: "in -cells only."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.295: They also suggest that Ca2+ uptake by the ER at basal [Ca2+]c is attributable to SERCA2b rather than SERCA3. 

Phrase: "They also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Ca2+ uptake by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "at basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "is"

Phrase: "attributable to SERCA2b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596130:Attributable [Mental Process]

Phrase: "rather than"

Phrase: "SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.296: In contrast, the contribution of SERCA3 becomes important when [Ca2+]c increases. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the contribution of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "becomes"

Phrase: "important"

Phrase: "when"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c increases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]
Processing 00000000.tx.297: The distinct roles of the two SERCA isoforms are compatible with their respective affinities for Ca2+ (1,10,11,44). 

Phrase: "The distinct roles of the two SERCA isoforms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0035820:Roles [Social Behavior]
   704 E C1705810:Role [Conceptual Entity]

Phrase: "are"

Phrase: "compatible with their respective affinities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]

Phrase: "for Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10,"

Phrase: "11,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.298: Activation of SERCA3 by a rise in [Ca2+]c has an impact on [Ca2+]c oscillations induced by periodic Ca2+ influx. 

Phrase: "Activation of SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by a rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "has"

Phrase: "an impact on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "induced by periodic Ca2+ influx."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205263:Induced [Functional Concept]
   760   C0332182:Periodic [Temporal Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706381:PERIODIC [Intellectual Product]
Processing 00000000.tx.299: Indeed, SERCA3 allows the ER to rapidly buffer Ca2+ during the upstroke of each oscillation, thereby limiting the amplitude of [Ca2+]c oscillations. 

Phrase: "Indeed,"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the ER to rapidly buffer Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "during the upstroke"

Phrase: "of each oscillation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0695434:oscillation [Therapeutic or Preventive Procedure]

Phrase: "thereby"

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "the amplitude of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]
Processing 00000000.tx.300: Once Ca2+ influx stops, [Ca2+]c decreases, but Ca2+ accumulated in the ER is slowly released into the cytosol, thereby prolonging the [Ca2+]c oscillation. 

Phrase: "Once Ca2+ influx stops,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0450446:Stops [Manufactured Object]
   779 E C1947925:Stop [Activity]
   779 E C2746065:Stop [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c decreases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "but"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "accumulated in the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "released into the cytosol,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1383501:Cytosol [Cell Component]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "thereby"

Phrase: "prolonging"

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.301: These effects of SERCA3 do not seem to have a major impact on insulin secretion. 

Phrase: "These effects of SERCA3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a major impact on insulin secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.302: Although differences of the pulsatility of secretion may occur in the absence of SERCA3, no diabetes develops in these mice. 

Phrase: "Although"

Phrase: "differences of the pulsatility of secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "occur in the absence of SERCA3,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332197:absence [Quantitative Concept]
   753   C1412639:SERCA3 [Gene or Genome]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "no diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "develops in these mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
Processing 00000000.tx.303: Even if SERCA3 seems dispensable for normal insulin response, it might play other roles in -cells. 

Phrase: "Even"

Phrase: "if"

Phrase: "SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: "seems"

Phrase: "dispensable for normal insulin response,"

Phrase: "it"

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "other roles in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.304: The observation that [Ca2+]c oscillations were different in SERCA3 +/+ and SERCA3 -/- islets corroborates the previous proposal that the membrane potential of -cells is modulated by the ER (21) and suggests that this control involves SERCA3. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "different in SERCA3 +/+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "and"

Phrase: "SERCA3 -/- islets"

Phrase: "corroborates"

Phrase: "the previous proposal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555306:proposal [Idea or Concept]
   861   C1948033:Proposal [Intellectual Product]

Phrase: "that"

Phrase: "the membrane potential of -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0007603:membrane cell [Cell Component]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "modulated by the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0443264:Modulated [Spatial Concept]

Phrase: "(21"

Phrase: ")"

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "involves"

Phrase: "SERCA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]
Processing 00000000.tx.305: Several studies reported that the Ca2+ content of the ER is important for synthesis, modifications, and folding of proteins (49,50). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the Ca2+ content of the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "is"

Phrase: "important for synthesis,"

Phrase: "modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "folding of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0162847:folding protein [Molecular Function]
   790   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.306: It is possible that cyclic elevations of the Ca2+ concentration within the ER during [Ca2+]c oscillations play a role in this process (49).  

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that cyclic elevations of the Ca2+ concentration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702240:elevations [Spatial Concept]
   714 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "within the ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "during"

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.307: ACKNOWLEDGMENTS  This work was supported by grant 3.4552.98 from the Fonds de la Recherche Scientifique Mdicale (Brussels), grants 2.4614.99 and 1.5.133.00 from the Fonds National de la Recherche Scientifique (Brussels), grant ARC 00/05260 from the General Direction of Scientific Research of the French Community of Belgium, National Institutes of Health grant HL61974, and by the Interuniversity Poles of Attraction Program P5/3/20, Belgian State, Prime Ministers Office, Federal Office for Scientific, Technical and Cultural Affairs. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grant 3.4552.98"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0018173:Grant [Quantitative Concept]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   719 E C0183683:Support [Medical Device]

Phrase: "from the Fonds de la Recherche Scientifique Mdicale"

Phrase: "(Brussels"

Phrase: ")"

Phrase: ","

Phrase: "grants 2.4614.99"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "1.5.133.00"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450316:1/5 [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "from the Fonds National de la Recherche Scientifique"

Phrase: "(Brussels"

Phrase: ")"

Phrase: ","

Phrase: "grant ARC 00/05260 from the General Direction of Scientific Research"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0683933:scientific research [Research Activity]
   754   C0260206:research grant [Research Activity]
   738   C0018173:Grant [Quantitative Concept]
   738   C0035168:research [Research Activity]
   738   C0036397:Scientific [Occupation or Discipline]
   738   C0205246:General [Spatial Concept]
   738   C0242481:Research [Research Activity]
   738   C0449738:Direction [Spatial Concept]
   738   C1548284:Grant [Idea or Concept]
   738   C1553889:General [Idea or Concept]

Phrase: "of the French Community"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009462:Community [Geographic Area]

Phrase: "of Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "National Institutes of Health grant HL61974,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "and by the Interuniversity Poles of Attraction Program P5/3/20,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   738   C0337815:Poles [Population Group]
   738   C1515981:And [Idea or Concept]
   738   C1538611:P5 [Gene or Genome]
   738   C1539371:p5 [Gene or Genome]
   738   C1709697:Program [Conceptual Entity]
   738   C2728259:Program [Pharmacologic Substance]
   738   C3484370:Program [Functional Concept]
   704 E C0935623:Pole [Body Location or Region]
   704 E C1418729:POLE [Gene or Genome]

Phrase: "Belgian State,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "Prime Ministers Office,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442603:Office [Manufactured Object]

Phrase: "Federal Office for Scientific, Technical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442603:Office [Manufactured Object]

Phrase: "and"

Phrase: "Cultural Affairs."
Processing 00000000.tx.308: The authors thank Alexandra Fivet for help with RT-PCR and Fabien Knockaert for insulin assays. 

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Alexandra Fivet for"

Phrase: "help with RT-PCR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0018896:Help [Social Behavior]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0040649:Transcription [Genetic Function]
   753   C0443286:Reaction [Functional Concept]
   753   C0677874:pCR [Finding]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1552861:help [Idea or Concept]
   753   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "Fabien Knockaert for insulin assays."
Processing 00000000.tx.309: P.G. is Senior Research Associate and J.-C.J. 

Phrase: "P.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "Senior Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "J.-C.J."
Processing 00000000.tx.310: Research Associate of the Fonds National de la Recherche Scientifique, Brussels.  

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Associate of the Fonds National de la Recherche Scientifique,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0011198:DE [Geographic Area]
   742   C0017480:DE [Geographic Area]
   742   C0023031:La [Element, Ion, or Isotope]
   742   C0750490:Associate [Idea or Concept]
   742   C1706221:Associate [Professional or Occupational Group]
   742   C3245503:national [Intellectual Product]
   742   C3541240:DE [Idea or Concept]

Phrase: "Brussels."
Processing 00000000.tx.311: FOOTNOTES  Address correspondence and reprint requests to Dr. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0686900:request [Functional Concept]
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.312: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.313: Gilon, Unit dEndocrinologie et Mtabolisme, University of Louvain Faculty of Medicine, UCL 55.30, Av. 

Phrase: "Gilon,"

Phrase: "Unit dEndocrinologie et Mtabolisme,"

Phrase: "University of Louvain Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015535:Faculty [Professional or Occupational Group]

Phrase: "UCL 55.30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450382:55 [Intellectual Product]

Phrase: "Av."
Processing 00000000.tx.314: Hippocrate 55, B-1200 Brussels, Belgium. 

Phrase: "Hippocrate 55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "B-1200 Brussels,"

Phrase: "Belgium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]
Processing 00000000.tx.315: E-mail: gilon{at}endo.ucl.ac.be . Received for publication 8 February 2002 and accepted in revised form 26 July 2002. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gilon{at}endo.ucl."

Phrase: "ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "be ."

Phrase: "Received for publication 8 February 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 26 July 2002."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.316: ACh, acetylcholine; 

Phrase: "ACh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "acetylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.317: [Ca2+]c, cytosolic-free Ca2+ concentration; 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "cytosolic-free Ca2+ concentration"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0086045:Concentration [Mental Process]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1383501:Cytosolic [Cell Component]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ";"
Processing 00000000.tx.318: ER, endoplasmic reticulum; 

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ";"
Processing 00000000.tx.319: IP3, Ins(1,4,5)P3; 

Phrase: "IP3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "Ins(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "P3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412751:P3 [Gene or Genome]
  1000   C1427831:P3 [Gene or Genome]
  1000   C1539372:p3 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.320: SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; 

Phrase: "SERCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "sarcoendoplasmic reticulum Ca2+-ATPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.321: TG, thapsigargin.  

Phrase: "TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "thapsigargin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.322: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Dode L, De Greef C, Mountian I, Attard M, Town MM, Casteels R, Wuytack F: Structure of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene: promoter analysis and alternative splicing of the SERCA3 pre-mRNA. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Dode L,"

Phrase: "De Greef C,"

Phrase: "Mountian I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Attard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Town MM,"

Phrase: "Casteels R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wuytack F"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: ":"

Phrase: "Structure of the human sarco/endoplasmic reticulum Ca2+-ATPase 3 gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C1517495:Gene Structure [Gene or Genome]
   746   C0314607:Human structural gene [Gene or Genome]
   738   C0678594:Structure [Spatial Concept]
   718 E C0017366:Structural gene [Gene or Genome]

Phrase: ":"

Phrase: "promoter analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "alternative splicing of the SERCA3 pre-mRNA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1622990:pre-mRNA splicing [Genetic Function]
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0086934:mRNA splicing [Genetic Function]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]
Processing 00000000.tx.323: J Biol Chem273 :13982 13994,1998[Abstract/Free FullText] East JM: Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology. 

Phrase: "J Biol Chem273"

Phrase: ":"

Phrase: "13982 13994,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] East JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Sarco(endo)plasmic reticulum calcium pumps"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0006726:Calcium [Inorganic Chemical]
   799   C0182537:pumps [Medical Device]
   799   C2936886:Calcium [Pharmacologic Substance]
   793   C0001476:Calcium pump [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1749451:calcium pump [Molecular Function]
   766 E C1706421:Pump [Manufactured Object]

Phrase: ":"

Phrase: "recent advances in our understanding of structure/function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0725066:Advance [Medical Device]

Phrase: "and"

Phrase: "biology."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.324: Mol Membr Biol17 :189 200,2000[Medline] Misquitta CM, Mack DP, Grover AK: Sarco/endoplasmic reticulum Ca2+ (SERCA)-pumps: link to heart beats and calcium waves. 

Phrase: "Mol Membr Biol17"

Phrase: ":"

Phrase: "189 200,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Misquitta CM,"

Phrase: "Mack DP,"

Phrase: "Grover AK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: ":"

Phrase: "Sarco/endoplasmic reticulum Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(SERCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")-"

Phrase: "pumps"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0182537:pumps [Medical Device]
   966 E C1706421:Pump [Manufactured Object]

Phrase: ":"

Phrase: "link to heart beats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "calcium waves."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0600430:Calcium Waves [Cell Function]
   861   C0678544:waves [Natural Phenomenon or Process]
   827 E C1421479:WAVE [Gene or Genome]
Processing 00000000.tx.325: Cell Calcium25 :277 290,1999[Medline] Wu KD, Lee WS, Wey J, Bungard D, Lytton J: Localization and quantification of endoplasmic reticulum Ca2+-ATPase isoform transcripts. 

Phrase: "Cell Calcium25"

Phrase: ":"

Phrase: "277 290,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Lee WS,"

Phrase: "Wey J,"

Phrase: "Bungard D,"

Phrase: "Lytton J"

Phrase: ":"

Phrase: "Localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "quantification of endoplasmic reticulum Ca2+-ATPase isoform transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709793:Quantification [Quantitative Concept]
Processing 00000000.tx.326: Am J Physiol269 :C775 C784,1995[Abstract] Vradi A, Molnr E, stenson CG, Ashcroft SJH: Isoforms of endoplasmic reticulum Ca2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans. 

Phrase: "Am"

Phrase: "J Physiol269"

Phrase: ":"

Phrase: "C775 C784,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vradi A,"

Phrase: "Molnr E,"

Phrase: "stenson CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Ashcroft SJH"

Phrase: ":"

Phrase: "Isoforms of endoplasmic reticulum Ca2+-ATPase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic islets of Langerhans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets
Processing 00000000.tx.327: Biochem J319 :521 527,1996[Medline] Lytton J, Zarain-Herzberg A, Periasamy M, MacLennan DH: Molecular cloning of the mammalian smooth muscle sarco(endo)plasmic reticulum Ca2+-ATPase. 

Phrase: "Biochem J319"

Phrase: ":"

Phrase: "521 527,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lytton J,"

Phrase: "Zarain-Herzberg A,"

Phrase: "Periasamy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "MacLennan DH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: ":"

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "of the mammalian smooth muscle sarco(endo)plasmic reticulum Ca2+-ATPase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]
   807   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.328: J Biol Chem264 :7059 7065,1989[Abstract/Free FullText] Periasamy M, Reed TD, Liu LH, Ji Y, Loukianov E, Paul RJ, Nieman ML, Riddle T, Duffy JJ, Doetschman T, Lorenz JN, Shull GE: Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. 

Phrase: "J Biol Chem264"

Phrase: ":"

Phrase: "7059 7065,"

Phrase: "1989"

Phrase: "[Abstract/Free FullText"

Phrase: "] Periasamy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reed TD,"

Phrase: "Liu LH,"

Phrase: "Ji Y,"

Phrase: "Loukianov E,"

Phrase: "Paul RJ,"

Phrase: "Nieman ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Riddle T,"

Phrase: "Duffy JJ,"

Phrase: "Doetschman T,"

Phrase: "Lorenz JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Shull GE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: ":"

Phrase: "Impaired cardiac performance in heterozygous mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0597198:Performance [Individual Behavior]
   753   C1882330:Performance [Activity]

Phrase: "with a null mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]
   812   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0014175:Endo [Disease or Syndrome]
   793   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   793   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   793   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   793   C1427293:ENDO [Gene or Genome]
   793   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SERCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916183:serca2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412638:SERCA2 [Gene or Genome]

Phrase: ")"

Phrase: "gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.329: J Biol Chem274 :2556 2562,1999[Abstract/Free FullText] Shull GE: Gene knockout studies of Ca2+-transporting ATPases. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "2556 2562,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shull GE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: ":"

Phrase: "Gene knockout"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599772:Gene Knockout [Molecular Biology Research Technique]
   861   C0560617:knock out [Injury or Poisoning]
   861   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "studies of Ca2+-transporting ATPases."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   851   C0001476:Ca2+-transporting ATPase [Amino Acid, Peptide, or Protein,Enzyme]
           Ca2+ ATPase
   760   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0557651:Study [Manufactured Object]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   726   C3495449:transport [Medical Device]
Processing 00000000.tx.330: Eur J Biochem267 :5284 5290,2000[Abstract/Free FullText] Burk SE, Lytton J, MacLennan DH, Shull GE: cDNA cloning, functional expression, and mRNA tissue distribution of a third organellar Ca2+ pump. 

Phrase: "Eur J Biochem267"

Phrase: ":"

Phrase: "5284 5290,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Burk SE,"

Phrase: "Lytton J,"

Phrase: "MacLennan DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Shull GE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: ":"

Phrase: "cDNA cloning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "functional expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mRNA tissue distribution of a third organellar Ca2+ pump."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0040287:Tissue Distribution [Quantitative Concept]
   764   C0220927:tissue distribution [Functional Concept]
   742   C0040300:Tissue [Tissue]
   742   C0520511:distribution [Idea or Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.331: J Biol Chem264 :18561 18568,1989[Abstract/Free FullText] Wuytack F, Dode L, Baba-Aissa F, Raeymaekers L: The SERCA3-type of organellar Ca2+ pumps. 

Phrase: "J Biol Chem264"

Phrase: ":"

Phrase: "18561 18568,"

Phrase: "1989"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wuytack F,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "Dode L,"

Phrase: "Baba-Aissa F,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "Raeymaekers L"

Phrase: ":"

Phrase: "The SERCA3-type of organellar Ca2+ pumps."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.332: Biosci Rep15 :299 306,1995[Medline] Lytton J, Westlin M, Burk SE, Shull GE, MacLennan DH: Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. 

Phrase: "Biosci Rep15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1835811:REP15 [Gene or Genome]

Phrase: ":"

Phrase: "299 306,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lytton J,"

Phrase: "Westlin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Burk SE,"

Phrase: "Shull GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "MacLennan DH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: ":"

Phrase: "Functional comparisons between isoforms of the sarcoplasmic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707455:Comparison [Activity]

Phrase: "or"

Phrase: "endoplasmic reticulum family of calcium pumps."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.333: J Biol Chem267 :14483 14489,1992[Abstract/Free FullText] Lee MG, Xu X, Zeng WZ, Diaz J, Kuo TH, Wuytack F, Racymaekers L, Muallem S: Polarized expression of Ca2+ pumps in pancreatic and salivary gland cells: role in initiation and propagation of [Ca2+]i waves. 

Phrase: "J Biol Chem267"

Phrase: ":"

Phrase: "14483 14489,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Xu X,"

Phrase: "Zeng WZ,"

Phrase: "Diaz J,"

Phrase: "Kuo TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Wuytack F,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "Racymaekers L,"

Phrase: "Muallem S"

Phrase: ":"

Phrase: "Polarized expression of Ca2+ pumps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in pancreatic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "salivary gland cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0036098:Salivary gland [Body Part, Organ, or Organ Component]
   901   C1278917:Salivary gland [Body Part, Organ, or Organ Component]
   901   C1519177:GLAND, SALIVARY [Tissue]
   827   C0007634:Cells [Cell]
   827   C0442040:Salivary [Spatial Concept]
   827   C1285092:Gland [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "role in initiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "propagation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i waves."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678544:waves [Natural Phenomenon or Process]
   827 E C1421479:WAVE [Gene or Genome]
Processing 00000000.tx.334: J Biol Chem272 :15771 15776,1997[Abstract/Free FullText] Varadi A, Rutter GA: Dynamic imaging of endoplasmic reticulum Ca2+ concentration in insulin-secreting MIN6 cells using recombinant targeted cameleons: roles of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2 and ryanodine receptors. 

Phrase: "J Biol Chem272"

Phrase: ":"

Phrase: "15771 15776,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Varadi A,"

Phrase: "Rutter GA"

Phrase: ":"

Phrase: "Dynamic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0729333:Dynamic [Functional Concept]

Phrase: "imaging of endoplasmic reticulum Ca2+ concentration"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0086045:Concentration [Mental Process]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1446561:Concentration [Quantitative Concept]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "in insulin-secreting MIN6 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant targeted cameleons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0279281:CAMELEON [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "roles of sarco(endo)plasmic reticulum Ca2+-ATPase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0035820:Roles [Social Behavior]
   743   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]
   711 E C1705810:Role [Conceptual Entity]

Phrase: "(SERCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")-"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "ryanodine receptors."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0917729:Ryanodine Receptors [Amino Acid, Peptide, or Protein,Receptor]
   983 E C0054493:Ryanodine Receptor [Amino Acid, Peptide, or Protein,Receptor]
   983 E C1753335:ryanodine receptor [Molecular Function]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.335: Diabetes51 (Suppl. 1) :S190 S201,2002[Abstract/Free FullText] Henquin JC, Meissner HP: Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic -cells. 

Phrase: "Diabetes51"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S190 S201,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henquin JC,"

Phrase: "Meissner HP"

Phrase: ":"

Phrase: "Significance of ionic fluxes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "changes in membrane potential"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0025251:Membrane Potential [Cell Function]
   770   C0025255:Membrane [Tissue]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1705241:Change [Quantitative Concept]
   770   C1706182:Membrane [Manufactured Object]
   770   C3245505:Potential [Qualitative Concept]

Phrase: "for stimulus-secretion coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1948027:Coupling [Functional Concept]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.336: Experientia40 :1043 1052,1984[Medline] Gilon P, Henquin JC: Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin- secreting pancreatic -cell. 

Phrase: "Experientia40"

Phrase: ":"

Phrase: "1043 1052,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gilon P,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Influence of membrane potential changes"

Phrase: "on cytoplasmic Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in an electrically excitable cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "the insulin- secreting pancreatic -cell."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0030281:Insulin-secreting cell [Cell]
           Insulin Cell
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.337: J Biol Chem267 :20713 20720,1992[Abstract/Free FullText] Santos RM, Rosario LM, Nadal A, Garcia-Sancho J, Soria B, Valdeolmillos M: Widespread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. 

Phrase: "J Biol Chem267"

Phrase: ":"

Phrase: "20713 20720,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Santos RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Rosario LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Nadal A,"

Phrase: "Garcia-Sancho J,"

Phrase: "Soria B,"

Phrase: "Valdeolmillos M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Widespread synchronous"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0439580:Synchronous [Temporal Concept]
   861   C1547532:Synchronous. [Intellectual Product]
   745 E C0439579:Synchronicities [Temporal Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i oscillations due to bursting electrical activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "in single pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.338: Pflgers Archiv418 :417 422,1991[Medline] Maechler P, Kennedy ED, Sebo E, Valeva A, Pozzan T, Wollheim CB: Secretagogues modulate the calcium concentration in the endoplasmic reticulum of insulin-secreting cells: studies in aequorin-expressing intact and permeabilized Ins-1 cells. 

Phrase: "Pflgers Archiv418"

Phrase: ":"

Phrase: "417 422,"

Phrase: "1991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maechler P,"

Phrase: "Kennedy ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Sebo E,"

Phrase: "Valeva A,"

Phrase: "Pozzan T,"

Phrase: "Wollheim CB"

Phrase: ":"

Phrase: "Secretagogues"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the calcium concentration in the endoplasmic reticulum of insulin-secreting cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0086045:Concentration [Mental Process]
   738   C1446561:Concentration [Quantitative Concept]

Phrase: ":"

Phrase: "studies in aequorin-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "expressing"

Phrase: "intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "and"

Phrase: "permeabilized Ins-1 cells."
Processing 00000000.tx.339: J Biol Chem274 :12583 12592,1999[Abstract/Free FullText] Roe MW, Mertz RJ, Lancaster ME, Worley JF, III, Dukes ID: Thapsigargin inhibits the glucose-induced decrease of intracellular Ca2+ in mouse islets of Langerhans. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "12583 12592,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Mertz RJ,"

Phrase: "Lancaster"

Phrase: "ME,"

Phrase: "Worley JF,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "Dukes ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the glucose-induced decrease of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "of Langerhans."
Processing 00000000.tx.340: Am J Physiol266 :E852 E862,1994[Abstract/Free FullText] Tengholm A, Hellman B, Gylfe E: Glucose regulation of free Ca2+ in the endoplasmic reticulum of mouse pancreatic -cells. 

Phrase: "Am"

Phrase: "J Physiol266"

Phrase: ":"

Phrase: "E852 E862,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tengholm A,"

Phrase: "Hellman B,"

Phrase: "Gylfe E"

Phrase: ":"

Phrase: "Glucose regulation of free Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "of mouse pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.341: J Biol Chem274 :36883 36890,1999[Abstract/Free FullText] Gilon P, Henquin JC: Mechanisms and physiological significance of the cholinergic control of pancreatic -cell function. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "36883 36890,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gilon P,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "physiological significance of the cholinergic control of pancreatic -cell function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237881:Significance [Quantitative Concept]
   739   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.342: Endocr Rev22 :565 604,2001[Abstract/Free FullText] Gilon P, Arredouani A, Gailly P, Gromada J, Henquin JC: Uptake and release of Ca2+ by the endoplasmic reticulum contribute to the oscillations of the cytosolic Ca2+ concentration triggered by Ca2+ influx in the electrically excitable pancreatic -cell. 

Phrase: "Endocr Rev22"

Phrase: ":"

Phrase: "565 604,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gilon P,"

Phrase: "Arredouani A,"

Phrase: "Gailly P,"

Phrase: "Gromada J,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "release of Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0030685:Release [Health Care Activity]
   790   C0391871:Release [Functional Concept]
   790   C0439180:% release [Quantitative Concept]
   790   C0680255:release [Health Care Activity]
   790   C1283071:Release [Functional Concept]
   790   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "contribute to the oscillations of the cytosolic Ca2+ concentration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0086045:Concentration [Mental Process]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0695434:oscillations [Therapeutic or Preventive Procedure]
   742   C1383501:Cytosolic [Cell Component]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1880177:Contribute [Activity]

Phrase: "triggered by Ca2+ influx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1444748:Triggered by [Qualitative Concept]
           Trigger
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   737   C0032930:Trigger [Clinical Attribute]

Phrase: "in the electrically excitable pancreatic -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.343: J Biol Chem274 :20197 20205,1999[Abstract/Free FullText] Marie JC, Bailbe D, Gylfe E, Portha B: Defective glucose-dependent cytosolic Ca2+ handling in islets of GK and nSTZ rat models of type 2 diabetes. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "20197 20205,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Marie JC,"

Phrase: "Bailbe D,"

Phrase: "Gylfe E,"

Phrase: "Portha B"

Phrase: ":"

Phrase: "Defective glucose-dependent cytosolic Ca2+ handling in islets of GK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0018578:Handling [Behavior]
   739   C1832073:Handling [Finding]

Phrase: "and"

Phrase: "nSTZ rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "models of type 2 diabetes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.344: J Endocrinol169 :169 176,2001[Abstract/Free FullText] Henquin JC, Jonas JC, Sato Y, Detimary P, Gilon P: Signal transduction: regulation of insulin secretion by changes in Ca2+ concentration and action in pancreatic -cells. 

Phrase: "J Endocrinol169"

Phrase: ":"

Phrase: "169 176,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henquin JC,"

Phrase: "Jonas JC,"

Phrase: "Sato Y,"

Phrase: "Detimary P,"

Phrase: "Gilon P"

Phrase: ":"

Phrase: "Signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: ":"

Phrase: "regulation of insulin secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1325895:regulation of insulin secretion [Cell Function]
   881   C1523071:regulation of secretion [Cell Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in Ca2+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "action in pancreatic -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]
Processing 00000000.tx.345: In Advances in Molecular and Cell Biology. 

Phrase: "In Advances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0725066:Advance [Medical Device]

Phrase: "in Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cell Biology."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.346: E. 

Phrase: "E."
Processing 00000000.tx.347: Edward Bittar, Ed. 

Phrase: "Edward Bittar,"

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.348: Stamford, CT, JAI Press, p.247 275,1999 Levy J, Zhu ZX, Dunbar JC: The effect of glucose and calcium on Ca2+-adenosine triphosphatase in pancreatic islets isolated from a normal and a non-insulin-dependent diabetes mellitus rat model. 

Phrase: "Stamford,"

Phrase: "CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "JAI Press,"

Phrase: "p.247 275,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "1999 Levy J,"

Phrase: "Zhu ZX,"

Phrase: "Dunbar JC"

Phrase: ":"

Phrase: "The effect of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158774:glucose effect [Genetic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "calcium on Ca2+-adenosine triphosphatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0001476:Adenosine Triphosphatase, Calcium [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C2936886:Calcium [Pharmacologic Substance]

Phrase: "in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "isolated from a normal"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205307:Normal [Qualitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "a non-insulin-dependent diabetes mellitus rat model."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C3161035:Model [Intellectual Product]
   747   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   747   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   710   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
Processing 00000000.tx.349: Metabolism47 :185 189,1998[Medline] Roe MW, Philipson LH, Frangakis CJ, Kuznetsov A, Mertz RJ, Lancaster ME, Spencer B, Worley JF, Dukes ID: Defective glucose-dependent endoplasmic reticulum Ca2+ sequestration in diabetic mouse islets of Langerhans. 

Phrase: "Metabolism47"

Phrase: ":"

Phrase: "185 189,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Philipson LH,"

Phrase: "Frangakis CJ,"

Phrase: "Kuznetsov A,"

Phrase: "Mertz RJ,"

Phrase: "Lancaster"

Phrase: "ME,"

Phrase: "Spencer B,"

Phrase: "Worley JF,"

Phrase: "Dukes ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Defective glucose-dependent endoplasmic reticulum Ca2+ sequestration in diabetic mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0443301:Sequestration [Functional Concept]

Phrase: "of Langerhans."
Processing 00000000.tx.350: J Biol Chem269 :18279 18282,1994[Abstract/Free FullText] Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner WS, Weir GC: Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. 

Phrase: "J Biol Chem269"

Phrase: ":"

Phrase: "18279 18282,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jonas JC,"

Phrase: "Sharma A,"

Phrase: "Hasenkamp W,"

Phrase: "Ilkova H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Patane G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "Laybutt R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bonner WS,"

Phrase: "Weir GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: ":"

Phrase: "Chronic hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342300:Chronic hyperglycaemia [Pathologic Function]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "loss of pancreatic beta cell differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517945:Loss [Quantitative Concept]
   716   C2753705:pancreatic beta cell differentiation [Cell Function]

Phrase: "in an animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Animal Model [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Model [Intellectual Product]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.351: J Biol Chem274 :14112 14121,1999[Abstract/Free FullText] Varadi A, Lebel L, Hashim Y, Mehta Z, Ashcroft SJH, Turner R: Sequence variants of the sarco(endo)plasmic reticulum Ca2+-transport ATPase 3 gene (SERCA3) in caucasian type II diabetic patients (UH Prospective Diabetes Study 48). 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "14112 14121,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Varadi A,"

Phrase: "Lebel L,"

Phrase: "Hashim Y,"

Phrase: "Mehta Z,"

Phrase: "Ashcroft SJH,"

Phrase: "Turner R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Sequence variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]

Phrase: "of the sarco(endo)plasmic reticulum Ca2+-transport ATPase 3 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   842   C1413043:CA2 gene [Gene or Genome]
   817   C1706675:ATPase Gene [Gene or Genome]
   791   C0017337:Gene [Gene or Genome]
   733   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]

Phrase: "(SERCA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412639:SERCA3 [Gene or Genome]

Phrase: ")"

Phrase: "in caucasian type II diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "(UH Prospective Diabetes Study 48"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0033522:prospective study [Research Activity]
   853   C1709709:Prospective Study [Research Activity]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0023981:prospective [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.352: Diabetologia42 :1240 1243,1999[Medline] Xu GG, Gao Z, Borge PD, Jegier PA, Young RA, Wolf BA: Insulin regulation of -cell function involves a feedback loop on SERCA gene expression, Ca2+ homeostasis, and insulin expression and secretion. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "1240 1243,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Gao Z,"

Phrase: "Borge PD,"

Phrase: "Jegier PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Young RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Wolf BA"

Phrase: ":"

Phrase: "Insulin regulation of -cell function"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   875   C0030281:Insulin Cell [Cell]
   840   C0007613:Cell Function [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1705273:Function [Intellectual Product]
   804   C1948049:Cell [Spatial Concept]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]

Phrase: "involves"

Phrase: "a feedback loop on SERCA gene expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0419518:Loop [Medical Device]
   739   C0445022:Loop [Spatial Concept]

Phrase: "Ca2+ homeostasis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "insulin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.353: Biochemistry39 :14912 14919,2000[Medline] Liu LH, Paul RJ, Sutliff RL, Miller ML, Lorenz JN, Pun RY, Duffy JJ, Doetschman T, Kimura Y, MacLennan DH, Hoying JB, Shull GE: Defective endothelium-dependent relaxation of vascular smooth muscle and endothelial cell Ca2+ signaling in mice lacking sarco(endo)plasmic reticulum Ca2+ -ATPase isoform 3. 

Phrase: "Biochemistry39"

Phrase: ":"

Phrase: "14912 14919,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu LH,"

Phrase: "Paul RJ,"

Phrase: "Sutliff RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Miller ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Lorenz JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Pun RY,"

Phrase: "Duffy JJ,"

Phrase: "Doetschman T,"

Phrase: "Kimura Y,"

Phrase: "MacLennan DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Hoying JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Shull GE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: ":"

Phrase: "Defective endothelium-dependent relaxation of vascular smooth muscle"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   869   C2262829:relaxation of vascular smooth muscle [Organism Function]
           vascular smooth muscle relaxation
   822   C1258036:Vascular Endothelium-Dependent Relaxation [Organ or Tissue Function]
   819   C2249967:relaxation of smooth muscle [Organ or Tissue Function]
           smooth muscle relaxation
   793   C0026836:relaxation of muscle [Organ or Tissue Function]
           Muscle Relaxation
   767   C0014261:Endothelium, Vascular [Tissue]
   767   C0700323:Muscle relaxation [Disease or Syndrome]
   744   C0014257:Endothelium [Tissue]
   744   C0035028:Relaxation [Activity]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   739 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "and"

Phrase: "endothelial cell Ca2+ signaling in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0037083:Cell Signaling [Cell Function]
           Signaling
   753   C3537152:signaling [Biologic Function]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "sarco(endo)plasmic reticulum Ca2+ -ATPase isoform 3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]
   812   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0014175:Endo [Disease or Syndrome]
   793   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   793   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   793   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   793   C1427293:ENDO [Gene or Genome]
   793   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.354: J Biol Chem272 :30538 30545,1997[Abstract/Free FullText] Lytton J, Westlin M, Hanley MR: Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca2+-ATPase family of calcium pumps. 

Phrase: "J Biol Chem272"

Phrase: ":"

Phrase: "30538 30545,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lytton J,"

Phrase: "Westlin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hanley MR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: ":"

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the sarcoplasmic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0682566:Sarcoplasm [Cell Component]

Phrase: "or"

Phrase: "endoplasmic reticulum Ca2+-ATPase family of calcium pumps."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Family [Family Group]
   744   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.355: J Biol Chem266 :17067 17071,1991[Abstract/Free FullText] Wuytack F, Papp B, Verboomen H, Raeymaekers L, Dode L, Bobe R, Enouf J, Bokkala S, Authi KS, Casteels R: A sarco/endoplasmic reticulum Ca2+-ATPase 3-type Ca2+ pump is expressed in platelets, in lymphoid cells, and in mast cells. 

Phrase: "J Biol Chem266"

Phrase: ":"

Phrase: "17067 17071,"

Phrase: "1991"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wuytack F,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "Papp B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456825:PAPP-B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0135262:PAPP [Organic Chemical,Pharmacologic Substance]

Phrase: "Verboomen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Raeymaekers L,"

Phrase: "Dode L,"

Phrase: "Bobe R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Enouf J,"

Phrase: "Bokkala S,"

Phrase: "Authi KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Casteels R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "A sarco/endoplasmic reticulum Ca2+-ATPase 3-type Ca2+ pump"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0182537:Pump [Medical Device]
   791   C1706421:Pump [Manufactured Object]
   707   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   707   C2262324:sarco(endo)plasmic reticulum Ca2+-ATPase [Molecular Function]

Phrase: "is"

Phrase: "expressed in platelets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005821:Platelets [Cell]
   790   C1963076:Platelets [Finding]

Phrase: "in lymphoid cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086574:Lymphoid Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1518071:Lymphoid [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and in mast cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0024880:Mast Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0451297:MAST [Intellectual Product]
   770   C0684269:mast- [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1539838:MAST [Gene or Genome]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.356: J Biol Chem269 :1410 1416,1994[Abstract/Free FullText] vonWasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A: Tyramine amplification technique in routine immunohistochemistry. 

Phrase: "J Biol Chem269"

Phrase: ":"

Phrase: "1410 1416,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] vonWasielewski R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mengel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gignac S,"

Phrase: "Wilkens L,"

Phrase: "Werner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Georgii A"

Phrase: ":"

Phrase: "Tyramine amplification technique in routine immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449851:Technique [Functional Concept]
Processing 00000000.tx.357: J Histochem Cytochem45 :1455 1459,1997[Abstract/Free FullText] Ravier MA, Eto K, Jonkers FC, Nenquin M, Kadowaki T, Henquin JC: The oscillatory behavior of pancreatic islets from mice with mitochondrial glycerol-3-phosphate dehydrogenase knockout. 

Phrase: "J Histochem Cytochem45"

Phrase: ":"

Phrase: "1455 1459,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ravier MA,"

Phrase: "Eto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Jonkers FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Nenquin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kadowaki T,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "The oscillatory behavior of pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with mitochondrial glycerol-3-phosphate dehydrogenase knockout."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0560617:knock out [Injury or Poisoning]
   799   C1522225:Knock-out [Experimental Model of Disease]
   734   C0017875:Glycerol-3-Phosphate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.358: J Biol Chem275 :1587 1593,2000[Abstract/Free FullText] Jonkers FC, Jonas JC, Gilon P, Henquin JC: Influence of cell number on the characteristics and synchrony of Ca2+ oscillations in clusters of mouse pancreatic islet cells. 

Phrase: "J Biol Chem275"

Phrase: ":"

Phrase: "1587 1593,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jonkers FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Jonas JC,"

Phrase: "Gilon P,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Influence of cell number"

Phrase: "on the characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "synchrony of Ca2+ oscillations"

Phrase: "in clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "of mouse pancreatic islet cells."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   906   C0734999:Pancreatic islet cell [Cell]
   906   C1522528:Mouse Islet Cell [Tissue]
   861   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   827 E C1522529:Islet Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.359: J Physiol520 :839 849,1999[Abstract/Free FullText] Ravier MA, Gilon P, Henquin JC: Oscillations of insulin secretion can be triggered by imposed oscillations of cytoplasmic Ca2+ or metabolism in normal mouse islets. 

Phrase: "J Physiol520"

Phrase: ":"

Phrase: "839 849,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ravier MA,"

Phrase: "Gilon P,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Oscillations of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "triggered by imposed oscillations of cytoplasmic Ca2+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1444748:Triggered by [Qualitative Concept]
           Trigger
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0695434:oscillations [Therapeutic or Preventive Procedure]
   714   C0032930:Trigger [Clinical Attribute]

Phrase: "or"

Phrase: "metabolism in normal mouse islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.360: Diabetes48 :2374 2382,1999[Abstract] Miura Y, Gilon P, Henquin JC: Muscarinic stimulation increases Na+ entry in pancreatic -cells by a mechanism other than the emptying of intracellular Ca2+ pools. 

Phrase: "Diabetes48"

Phrase: ":"

Phrase: "2374 2382,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miura Y,"

Phrase: "Gilon P,"

Phrase: "Henquin JC"

Phrase: ":"

Phrase: "Muscarinic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Na+ entry in pancreatic -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "other than the emptying"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1996907:Emptying [Activity]
   966 E C1880497:Empty [Qualitative Concept]
   928 E C0333668:Depleted [Functional Concept]
   907 E C1550032:Unload [Idea or Concept]

Phrase: "of intracellular Ca2+ pools."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]
Processing 00000000.tx.361: Biochem Biophys Res Commun224 :67 73,1996[Medline] Rutter GA, Theler JM, Li G, Wollheim CB: Ca2+ stores in insulin-secreting cells: lack of effect of cADP ribose. 

Phrase: "Biochem Biophys Res Commun224"

Phrase: ":"

Phrase: "67 73,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rutter GA,"

Phrase: "Theler JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Li G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "Wollheim CB"

Phrase: ":"

Phrase: "Ca2+ stores in insulin-secreting cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1698986:Store [Functional Concept]

Phrase: ":"

Phrase: "lack of effect of cADP ribose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]
Processing 00000000.tx.362: Cell Calcium16 :71 80,1994[Medline] Tengholm A, Hellman B, Gylfe E: The endoplasmic reticulum is a glucose-modulated high-affinity sink for Ca2+ in mouse pancreatic -cells. 

Phrase: "Cell Calcium16"

Phrase: ":"

Phrase: "71 80,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tengholm A,"

Phrase: "Hellman B,"

Phrase: "Gylfe E"

Phrase: ":"

Phrase: "The endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "a glucose-modulated high-affinity sink for Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0183319:sink [Manufactured Object]
   744   C0337201:sink [Phenomenon or Process]

Phrase: "in mouse pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.363: J Physiol530 :533 540,2001[Abstract/Free FullText] Varadi A, Molnar E, Ashcroft SJ: A unique combination of plasma membrane Ca2+-ATPase isoforms is expressed in islets of Langerhans and pancreatic -cell lines. 

Phrase: "J Physiol530"

Phrase: ":"

Phrase: "533 540,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Varadi A,"

Phrase: "Molnar E,"

Phrase: "Ashcroft SJ"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: ":"

Phrase: "A unique combination of plasma membrane Ca2+-ATPase isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205195:Combination [Qualitative Concept]
   742   C1947911:Combination [Physical Object]

Phrase: "is"

Phrase: "expressed in islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   862   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "and"

Phrase: "pancreatic -cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.364: Biochem J314 :663 669,1996[Medline] Ashcroft FM, Rorsman P: Electrophysiology of the pancreatic -cell. 

Phrase: "Biochem J314"

Phrase: ":"

Phrase: "663 669,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Rorsman P"

Phrase: ":"

Phrase: "Electrophysiology of the pancreatic -cell."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0678837:cell electrophysiology [Cell Function]
   760   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
   760   C1446476:Electrophysiology [Diagnostic Procedure]
Processing 00000000.tx.365: Prog Biophys Mol Biol54 :87 143,1989[Medline] Liu YJ, Gylfe E: Store-operated Ca2+ entry in insulin-releasing pancreatic -cells. 

Phrase: "Prog Biophys Mol Biol54"

Phrase: ":"

Phrase: "87 143,"

Phrase: "1989"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu YJ,"

Phrase: "Gylfe E"

Phrase: ":"

Phrase: "Store-operated Ca2+ entry in insulin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.366: Cell Calcium22 :277 286,1997[Medline] Miura Y, Henquin JC, Gilon P: Emptying of intracellular Ca2+ stores stimulates Ca2+ entry in mouse pancreatic -cells by both direct and indirect mechanisms. 

Phrase: "Cell Calcium22"

Phrase: ":"

Phrase: "277 286,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miura Y,"

Phrase: "Henquin JC,"

Phrase: "Gilon P"

Phrase: ":"

Phrase: "Emptying of intracellular Ca2+ stores"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1996907:Emptying [Activity]
   726   C1698986:Store [Functional Concept]
   726 E C1880497:Empty [Qualitative Concept]

Phrase: "stimulates"

Phrase: "Ca2+ entry in mouse pancreatic -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]

Phrase: "by both direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "indirect mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.367: J Physiol503 :387 398,1997[Abstract] Louzao MC, Ribeiro CMP, Bird GStJ, Putney JW: Cell type-specific modes of feedback regulation of capacitative calcium entry. 

Phrase: "J Physiol503"

Phrase: ":"

Phrase: "387 398,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Louzao MC,"

Phrase: "Ribeiro CMP,"

Phrase: "Bird GStJ,"

Phrase: "Putney JW"

Phrase: ":"

Phrase: "Cell type-specific modes of feedback regulation of capacitative calcium entry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   704   C1513371:Mode [Functional Concept]
   704   C1705738:Mode [Quantitative Concept]
   704   C2347637:Mode [Quantitative Concept]
   704   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.368: J Biol Chem271 :14807 14813,1996[Abstract/Free FullText] Poch E, Leach S, Snape S, Cacic T, MacLennan DH, Lytton J: Functional characterization of alternatively spliced human SERCA3 transcripts. 

Phrase: "J Biol Chem271"

Phrase: ":"

Phrase: "14807 14813,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Poch E,"

Phrase: "Leach"

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Snape S,"

Phrase: "Cacic T,"

Phrase: "MacLennan DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Lytton J"

Phrase: ":"

Phrase: "Functional characterization of alternatively spliced human SERCA3 transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]
Processing 00000000.tx.369: Am J Physiol275 :C1449 C1458,1998[Abstract/Free FullText] Worley JF, III, McIntyre MS, Spencer B, Dukes ID: Depletion of intracellular Ca2+ stores activates a maitotoxin-sensitive nonselective cationic current in -cells. 

Phrase: "Am"

Phrase: "J Physiol275"

Phrase: ":"

Phrase: "C1449 C1458,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Worley JF,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "McIntyre MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Spencer B,"

Phrase: "Dukes ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Depletion of intracellular Ca2+ stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a maitotoxin-sensitive nonselective cationic current in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.370: J Biol Chem269 :32055 32058,1994[Abstract/Free FullText] Worley JF, III, McIntyre MS, Spencer B, Mertz RJ, Roe MW, Dukes ID: Endoplasmic reticulum calcium store regulates membrane potential in mouse islet -cells. 

Phrase: "J Biol Chem269"

Phrase: ":"

Phrase: "32055 32058,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Worley JF,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "McIntyre MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Spencer B,"

Phrase: "Mertz RJ,"

Phrase: "Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Dukes ID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ":"

Phrase: "Endoplasmic reticulum calcium store"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1698986:Store [Functional Concept]

Phrase: "regulates"

Phrase: "membrane potential in mouse islet -cells."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0025251:Membrane Potential [Cell Function]
   783   C0007603:cells membrane [Cell Component]
   767 E C3161472:Cell Membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.371: J Biol Chem269 :14359 14362,1994[Abstract/Free FullText] Montero M, Alvarez J, Scheenen WJ, Rizzuto R, Meldolesi J, Pozzan T: Ca2+ homeostasis in the endoplasmic reticulum: coexistence of high and low [Ca2+] subcompartments in intact HeLa cells. 

Phrase: "J Biol Chem269"

Phrase: ":"

Phrase: "14359 14362,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Montero M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Alvarez J,"

Phrase: "Scheenen WJ,"

Phrase: "Rizzuto R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Meldolesi J,"

Phrase: "Pozzan T"

Phrase: ":"

Phrase: "Ca2+ homeostasis in the endoplasmic reticulum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019868:Homeostasis [Biologic Function]

Phrase: ":"

Phrase: "coexistence of high"

Phrase: "and"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "] subcompartments in intact HeLa cells."
Processing 00000000.tx.372: J Cell Biol139 :601 611,1997[Abstract/Free FullText] Zhao XS, Shin DM, Liu LH, Shull GE, Muallem S: Plasticity and adaptation of Ca2+ signaling and Ca2+-dependent exocytosis in SERCA2(+/-) mice. 

Phrase: "J Cell Biol139"

Phrase: ":"

Phrase: "601 611,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhao XS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1421550:XS [Gene or Genome]

Phrase: "Shin DM,"

Phrase: "Liu LH,"

Phrase: "Shull GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Muallem S"

Phrase: ":"

Phrase: "Plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678558:Plasticity [Natural Phenomenon or Process]
   928 E C0032167:Plastic [Substance]

Phrase: "and"

Phrase: "adaptation of Ca2+ signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0000934:adaptation [Organism Function]
   770   C0392673:Adaptation [Biologic Function]

Phrase: "and"

Phrase: "Ca2+-dependent exocytosis in SERCA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0015283:Exocytosis [Cell Function]

Phrase: "(+/-"

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.373: EMBO J20 :2680 2689,2001[Abstract/Free FullText] Corbett EF, Michalak M: Calcium, a signaling molecule in the endoplasmic reticulum? 

Phrase: "EMBO J20"

Phrase: ":"

Phrase: "2680 2689,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Corbett EF,"

Phrase: "Michalak M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "a signaling molecule in the endoplasmic reticulum?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1519315:Signaling Molecule [Biologically Active Substance]
   748   C0567416:Molecule [Substance]
Processing 00000000.tx.374: Trends Biochem Sci25 :307 311,2000[Medline] Guest PC, Bailyes EM, Hutton JC: Endoplasmic reticulum Ca2+ is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic -cell. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci25"

Phrase: ":"

Phrase: "307 311,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guest PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Bailyes EM,"

Phrase: "Hutton JC"

Phrase: ":"

Phrase: "Endoplasmic reticulum Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "is"

Phrase: "important for the proteolytic processing"

Phrase: "and"

Phrase: "intracellular transport of proinsulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0599814:Intracellular Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in the pancreatic -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.375: Biochem J323 :445 450,1997[Medline]

Phrase: "Biochem J323"

Phrase: ":"

Phrase: "445 450,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

